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Timely changes of the circulating concentrations of haptoglobin and leptin in female cattle 
undergoing fat mobilization: assessment of the relevance of haptoglobin as an adipokine 
 
This study was undertaken to characterize the concentrations of haptoglobin (Hp) and leptin 
throughout the entire lactation period, to investigate the effect of long-term conjugated 
linoleic acids (CLA) supplementation on Hp and leptin in dairy cows, to examine the 
presence of Hp in bovine adipose tissue (AT), and to examine the effect of moderate feed 
restriction and re-feeding on Hp and leptin in non-lactating heifers. Samples from four 
different studies were used in this work. The first experiment “CLA-252 days in milk (DIM)” 
comprised heifers and cows observed from day (d) 21 ante partum (AP) until d 252 post 
partum (PP), receiving two doses of rumen-protected CLA supplementation (50 and 100 g/d, 
d 1 - 182 PP) versus a corresponding control group. A further experiment “CLA-post mortem 
(PM)-105 DIM” was done in heifers observed from d 21 AP until d 105 PP receiving either 
no CLA or 100 g/d CLA (d 1 - 105 PP). The CLA supplementation included equal 
proportions of each the t-10, c-12 and the c-9, t-11 isomer. The third experiment 
“Concentrate-roughage ratio” was conducted (d 21 AP - d 21 PP) using cows that received 
diets with either a concentrate-to-roughage ratio (dry matter basis (DM)) of 30:70% (low-
concentrate group) or 60:40% (high-concentrate group) after calving. The fourth experiment 
“Fat heifers restriction” was performed using non-lactating heifers fed either grass silage 
(100%) or grass silage diluted with straw (37:63 on DM basis). The physiological changes of 
Hp in the CLA-252 DIM experiment were related to parity and parturition. The 
concentrations of Hp were higher in heifers than in cows during the first week PP. The 
concentrations of Hp peaked around calving and decreased afterwards in both parity groups 
and CLA experiments. Long-term feeding of dairy cows with CLA had no effect on the 
concentrations of serum Hp. The animals in the concentrate-roughage ratio study had lower 
concentrations of Hp compared to those in the CLA studies. The immunohistochemistry and 
Western immunoblotting methods indicated the presence of Hp in bovine AT. The 
physiological changes in the concentrations of leptin in the CLA-252 DIM experiment were 
limited to parturition. Long-term feeding of dairy cows with CLA left the concentrations of 
leptin unaffected. The fat heifers restriction study indicated that neither Hp nor leptin 
concentrations were affected by the change in energy content of the ration fed. In conclusion, 
long-term feeding of dairy cows with CLA left the concentrations of Hp and leptin 
unaffected. The presence of Hp in bovine AT indicates that Hp can be classified as an 
adipokine in cattle. The lack of an evident relation between Hp and body fatness makes Hp 
irrelevant as an adiposity marker for ruminants. 
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Zeitlicher Verlauf der zirkulierenden Konzentrationen von Haptoglobin und Leptin in 
weiblichen Rindern, die eine Fettmobilisierung durchleben: Einschätzung der Relevanz 
von Haptoglobin als Adipokin   
 
Diese Studie wurde durchgeführt, um die Blut-konzentrationen von Haptoglobin (Hp) und 
Leptin über die gesamte Laktation zu charakterisieren, um den Langzeiteffekt der 
Supplementierung von konjugierten Linolsäuren (CLA) auf Hp und Leptin in Milchkühen zu 
prüfen und die Anwesenheit von Hp in bovinem Fettgewebe zu untersuchen. Außerdem 
wurde der Effekt einer moderaten Futterrestriktion mit anschließender Wiederaufnahme der 
Fütterung auf Hp und Leptin in nicht-laktierenden Färsen ermittelt. Proben aus vier 
verschiedenen Studien wurden in dieser Arbeit verwendet: Der erste Versuch “CLA-252 
DIM” beinhaltete Färsen und Kühe (untersucht von d 21 ante partum (AP) bis d 252 post 
partum (PP)), die von d 1 - 182 PP mit 0, 50 oder 100 g/d pansengeschützten CLA 
supplementiert wurden. Ein weiterer Versuch “CLA-post mortem (PM)-105 DIM” wurde mit 
Färsen durchgeführt; diese wurden von d 21 AP bis d 105 PP untersucht und erhielten 100 g/d 
CLA oder ein CLA-freies Kontrollsupplement. Die zugefütterten CLA enthielten zu gleichen 
Teilen das t-10, c-12 und das c-9, t-11 Isomer. Der dritte Versuch “Kraftfutter-Rauhfutter- 
Verhältnis” (KF:R) (d 21 AP - d 21 PP) wurde mit Kühen durchgeführt, deren Rationen nach 
der Kalbung, bezogen auf Trockenmasse geringe (KF:R = 30:70%) oder hohe (KF:R = 
60:40%) KF-Anteile enthielten. Der vierte Versuch “Fette Färsen” wurde mit nicht-
laktierenden Färsen durchgeführt, die entweder mit Grassilage (100%) oder mit durch Stroh 
verdünnte Grassilage (37:63 bezogen auf Trockenmasse) gefüttert wurden. Die 
physiologischen Veränderungen von Hp im CLA-252 DIM Versuch standen im 
Zusammenhang zu Parität und Geburt. Die Hp-Konzentrationen in der ersten Woche nach der 
Geburt waren bei Färsen höher als bei Kühen. In beiden Paritätsgruppen und CLA-Versuche 
konnte gezeigt werden, dass die Hp-Konzentration ihr Maximum zum Zeitpunkt der Geburt 
hatte und anschließend wieder absank. Mit der Langzeitfütterung von CLA konnten keine 
Veränderungen der Hp-Serum Konzentrationen erkannt werden. Die Tiere des Versuches 
“KF:R” hatten niedrigere Hp-Konzentrationen im Vergleich zu denen der CLA-Versuche. 
Durch Immunhistochemie und Western Blot konnte die Anwesenheit von Hp in bovinen 
Fettgewebe gezeigt werden. Die physiologischen Veränderungen der Leptinkonzentrationen 
im CLA-252 DIM Versuch waren auf den Zeitraum der Geburt begrenzt. Die CLA-
Langzeitfütterung der Milchkühe ließ die Leptinkonzentration unbeeinflusst. Der Versuch mit 
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fetten Färsen deutete drauf hin, dass weder Hp- noch Leptinkonzentrationen durch die 
Veränderung des Energiegehaltes des Futters beeinflusst waren. Zusammenfassend konnte 
gezeigt werden, dass Langzeitfütterung von Milchkühen mit CLA zu keiner Veränderung der 
Hp- und Leptinkonzentrationen führte. Die Anwesenheit von Hp in bovinem Fettgewebe 
bestätigt, dass Hp in Wiederkäuern als Adipokin klassifiziert werden kann. Der fehlende 
Zusammenhang zwischen Hp und Körperfettgehalt disqualifiziert Hp als Marker für den 
Körperfettgehalt in Wiederkäuern.  
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1. Introduction 
 
Livestock play a vital role in agricultural and rural economies of the world. Not only do they 
produce food directly but also they provide key inputs to crop agriculture and are a crucial 
link in nutrient cycles. Cattle are producers of both milk and meat and contribute greatly to 
human food supply. Over the last 50 years, dairy farming has become more intensive to 
increase the amount of milk produced by each cow. Dairy breeds such as Holstein Friesian 
have been selected to produce a very high yield of milk around 55 kg/day (d) (Breves, 2007). 
However, dairy cattle production exposes animals to a variety of stressors which can reduce 
feed intake and disease resistance. For instance, 50% of cows have one or more adverse health 
events during the periparturient period (Ferguson, 2001). During this period, the energy 
requirements can not entirely be met through dietary intake resulting in a condition of 
negative energy balance (NEB), as a consequence extensive metabolic and endocrine changes 
occur in dairy cows to accommodate parturition and lactogenesis (Bell, 1995). High-yielding 
dairy cows are then susceptible to various metabolic diseases, impaired immune function and 
fertility (Butler and Smith, 1989; Mallard et al., 1998). Dairy cattle production has been 
looking for more efficient and effective ways to minimize the health problems for a long time. 
Therefore, dietary adjustments that could enhance homeostasis and health status are given a 
broader scope (Bassaganya-Riera et al., 2001). In the last decade, there was sharply increased 
interest of the physiological effects of various fatty acids (FA), in particular to investigate the 
conjugated linoleic acids (CLA), which are naturally included in the milk and meat of 
ruminants, due to the potentially beneficial effects in terms of animal welfare, nutritional 
status and diseases. Besides the nutritional strategies, measurement of acute phase proteins 
(APPs) and hormonal concentrations can also be used to enhance cattle health and welfare 
status. 
 
1.1. Transition period  
 
The transition or periparturient period, beginning three weeks before calving and ending three 
weeks post-calving, clearly is the most critical phase of the lactation cycle for dairy cows 
(Grummer, 1995). This period is associated with elevated incidence of diseases such as 
mastitis, milk fever, metritis, ketosis, retained fetal membranes and displaced abomasum 
(Mulligan and Doherty, 2008). During this time, transition cows experience alterations related 
to increases in energy demands driven by both fetal growth requirements and lactogenesis 
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(Bell, 1995), and alterations related to metabolic, physical, behavioral and hormonal changes 
around parturition which are marked by a reduction in dry matter intake (DMI) (Allen et al., 
2005). Consequently, cows enter a situation of NEB. However, a significant adaptation to 
NEB is the mobilization of fat from body stores with release of nonesterified fatty acids 
(NEFA) into blood. In muscular tissue, proteolysis is increased and the mobilized amino acids 
contribute as substrates in the gluconeogenesis and milk protein synthesis (Herdt, 2000). The 
concentration of NEFA in blood reflects the degree of adipose tissue (AT) mobilization 
(Pullen et al., 1989). When the concentration of NEFA in blood increases around calving or in 
early lactation, more NEFA are taken up by the liver (Reynolds et al., 2003). In the liver, 
NEFA can be (1) completely oxidized to carbon dioxide to provide energy for the liver; (2) 
partially oxidized to produce ketone bodies such as β-hydroxybutyrate (BHB) that are 
released into the blood and serve as fuels for other tissues; or (3) reconverted to triglycerides 
(Drackley, 1999). A part of the triglyceride produced is exported out of the cells in the form 
of lipoproteins, of which very low density lipoproteins (VLDL) constitute the largest part 
(Drackley, 1999). If NEFA uptake by the liver becomes excessive, fatty liver may develop 
when the synthesis of triglycerides exceeds hepatic export capacity (Bobe et al., 2004). 
Negative energy balance and glucose deficit after calving also lead to increased production of 
BHB, which can result in clinical or subclinical ketosis (Herdt, 2000). Thus, increased 
circulating NEFA and BHB are highly associated with periparturient disorders and diseases 
(Herdt, 2000; Bobe et al., 2004). Moreover, the higher concentration of NEFA around calving 
could be related to inflammation (Kováč et al., 2009); thereby increasing susceptibility to 
inflammatory diseases including mastitis and metritis. Elevated plasma NEFA and BHB 
concentrations are usually accompanied by a reduction of plasma glucose, insulin and growth 
hormone (GH) concentrations, which reflects the greater glucose demand with the onset of 
lactation.  
 
1.2. Adipose tissue 
 
Adipose tissue is a type of loose connective tissue comprised of lipid-filled cells termed as 
adipocytes. Besides adipocytes, it contains connective tissue matrix, nerve cells, 
stromovascular cells (e.g. preadipocytes, fibroblast-like cells), and immune cells (Frayn et al., 
2003). Adipose tissue provides a virtually limitless storage site for energy in form of 
triglycerides, which are mobilized through lipolytic pathways to provide fuel to other organs. 
There are two types of AT existing in mammals: brown and white AT. Brown AT contains 
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several small lipid droplets and high numbers of mitochondria, its main role is to generate 
body heat particularly in neonates and hibernating species (Tran and Kahn, 2010). White AT, 
the predominant type of AT, is characterized by spherical adipocytes with a single lipid 
inclusion, eccentrically located nucleus and a small volume of cytoplasmic material at the cell 
periphery (Shen et al., 2003). However, only the white AT will be further addressed in this 
work. White AT is an active endocrine organ that secretes a variety of bioactive molecules 
called adipokines or adipocytokines. These adipokines include hormones implicated in energy 
balance (EB) (e.g. leptin, adiponectin), glucose tolerance and insulin sensitivity (e.g. 
adiponectin, resistin), cytokines (e.g. Interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α)), 
and proteins involved in lipid metabolism (e.g. retinol binding protein, cholesteryl ester 
transfer protein), vascular homeostasis (e.g. plasminogen activator inhibitor-1, 
angiotensinogen), and in inflammation and stress responses (haptoglobin (Hp), 
metallothionein) (Trayhurn and Wood, 2004). White AT is consisting of different depots 
which are located in specific regions of the body. These depots are categorized into 
subcutaneous (SC) and internal AT. The SC depot comprises the fat layer found between the 
dermis and the aponeuroses and fasciae of the muscles, and anatomically is subdivided into 
superficial and deep SC AT (Shen et al., 2003). The internal AT is located around the internal 
organs, divided into visceral (VC; e.g. intrathoracic, intraabdominopelvic (e.g. omental, 
mesenteric, retroperitoneal)), and non-visceral (distributed among muscles and adjacent to 
bones) fat (Shen et al., 2003). 
 
The AT depots are different in terms of their metabolic functions according to the anatomic 
location of each depot, e.g. in human obesity, VC depots (omental) show a stronger 
connection with metabolic disorders (e.g. insulin resistance, type 2 diabetes), while SC depots 
are associated with improved insulin sensitivity and a lower risk of developing type 2 diabetes 
mellitus (Pérez-Pérez et al., 2009; Tran and Kahn, 2010). Subcutaneous AT secretes 
adiponectin more abundantly than VC AT (Nakamura et al., 2009), whereby this adipokine is 
associated with improvement of insulin sensitivity (Kim et al., 2007). In contrast, resistin and 
retinol-binding protein are associated with insulin resistance and type 2 diabetes mellitus, 
which are more abundantly secreted from VC than SC AT (Klöting et al., 2007). The omental 
but not the SC fat drains into the portal vein, and releases excess NEFA which interferes with 
the liver metabolism and contributes to glucose intolerance and other metabolic complications 
associated with human obesity (Pérez-Pérez et al., 2009). The metabolic differences among 
depots are also reported in cattle. In this regard, Hishikawa et al. (2005) reported that 
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adipocytes in the SC and VC depots showed differences in their basal metabolic properties 
such as regulating volume and lipid composition; also they present differential gene 
expression profiles. 
 
1.3. Immune system  
 
Animals undergo challenges to their state of health, and are protected by the immune system 
that consists of a complex network of cells and soluble mediators. The immune system is 
classified into two categories: innate and adaptive (acquired) immunity, which are highly 
interactive and coordinated to provide an optimal resistance to infectious diseases. Innate 
immunity is not specific for a particular antigen. The innate immune response is the first and 
fast-acting line of host defense against the invading pathogens; this response can be localized 
within affected tissues or mobilized to the site of infection (systemic). Components of the 
innate defense include the physical barrier of the skin and mucous epithelia, leukocytes 
(macrophages, neutrophils and natural killer cells), non immune cells (epithelial and 
endothelial cells), and certain soluble mediators (cytokines, eicosanoids and APPs). Acquired 
or specific immunity is triggered if the pathogen is able to evade or is not completely 
eliminated by the innate defense system, and it involves cells called lymphocytes (B and T 
cells). If the host should encounter with the same antigen more than once, immune reactivity 
will occur as a consequence of the immunological memory. Inflammation is one of the 
hallmarks and first responses of the innate immune system to infection, and is associated with 
heat, redness, pain, swelling and impaired function. It has two main functions in order to 
remove the injurious agents and to initiate the tissue healing process. The above mentioned 
section is summarized according to Lippolis (2008) and Sordillo et al. (2009). The local 
inflammation that develops at the site of infection induces the acute phase response (APR).  
 
1.4. Acute phase response and acute phase proteins 
 
The APR is a complex systemic innate-defense system activated by trauma, infection, stress 
and inflammation to prevent tissue damage, eliminate any infective organisms and activate 
the repairing processes in order to restore homeostasis. It is induced by the release of 
inflammatory cytokines, especially Interleukin-1 (IL-1), IL-6 and TNF-α from the 
macrophages or blood monocytes at the site of inflammatory lesions or infections. These 
inflammatory mediators set of both the local effects on adjacent cells (leukocytes, fibroblasts, 
smooth muscle cells and endothelial cells), and systemic effects on other organs that can be 
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reached through the blood stream. Liver is the main site of synthesis of most APPs. Cytokines 
therefore act like mediators between the local site of injury and the hepatocytes (liver) to 
produce and release the APPs. Cytokines can also act indirectly on the APPs production via 
the hypothalamic-pituitary-adrenal (HPA) axis, which involves the secretion of corticotropin-
releasing hormone (CRH) and the adrenocorticotropic hormone (ACTH), and subsequent 
production of cortisol. However, IL-6 is the major stimulator for the hepatocytic secretion of 
most APPs. The APPs are defined as proteins whose plasma concentrations increase or 
decrease classifying them into positive (e.g. C-reactive protein (CRP), serum amyloid A 
(SAA), Hp), and negative (e.g. albumin, transferrin, transcortin) APPs, respectively. The 
maximum concentrations are usually reached within 24 - 48 h after stimulation and decline 
with recovery from the infection. The above mentioned section is based on the review of Jain 
et al. (2011). Acute phase proteins’ changes reflect the presence and intensity of 
inflammation, and they have long been used as a clinical guide for diagnosis (Petersen et al., 
2004). The production of APPs differs among species with regard to their increase in 
concentrations in response to stimuli. In humans, CRP and SAA showed the highest increases 
during an APR (Jain et al., 2011). C-reactive protein, Hp and pig major APP (pig-MAP) are 
major APPs in pigs (Carpintero et al., 2005). In cattle, there are two major APPs, Hp and 
SAA which both increase during tissue injury and disease (Grönlund et al., 2005). This work 
will mainly focus on Hp as one of the strongly reacting APPs in cattle. 
 
1.4.1. Haptoglobin 
 
1.4.1.1. Structure and phenotypes 
 
Haptoglobin is an α2-glycoprotein with haemoglobin (Hb)-binding capacity, originally 
synthesized as a single αβ polypeptide which is cleaved by a protease into α and β chains, and 
then covalently linked via disulfide bonds producing the mature Hp (Kurosky et al., 1980). 
Glycosylation is an enzymatic process that attaches glycans to proteins, lipids or other organic 
molecules, which regulates the configuration and function of glycoproteins. For instance, 
human Hp is a liver-secreted serum glycoprotein with four potential N-glycosylation sites on 
its β chain (Shu et al., 2011). However, there are two major α chain sub-units; a shorter (α1) 
and a longer (α2) variation. The α1 and α2 chains form a link to one and two other α chains, 
respectively. The Hp gene is characterized by two common alleles, Hp 1 and Hp 2. The two 
alleles give rise to three different phenotypes (Fig. 1), which are composed of two α1β units 
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(in Hp 1-1), two α1β and variable numbers of α2β units (in Hp 2-1), or variable numbers of 
α2β units (in Hp 2-2) (Cheng et al., 2007; Lai et al., 2008). Although Hp is found in serum of 
all mammals, this polymorphism (Hp 1-1, Hp 2-1 and Hp 2-2) exists only in humans, while it 
has been suggested that the structure of Hp in ruminants is similar to human Hp 2-2 (Lai et 
al., 2008). Bovine Hp consists of multiple α and β subunits with respective molecular weights 
reported as 16 kDa (α-chains) and 40 kDa (β-chains) (Eckersall and Conner, 1990) or 20 kDa 
peptide (α-chains) and 35 kDa glycopeptide (β-chains) (Morimatsu et al., 1991). In 
circulation, it is highly polymerized having a molecular weight of approximately 1000-2000 
kDa (Godson et al., 1996).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1. A schematic model illustrating the structure of human Hp phenotypes. Hp 1-1 
represents a homodimer, the simplest combination of dimeric α1β chains (α1β)2. Hp 2-
2 is heterogeneous in size, starting with cyclic trimeric α2β chains (α2β)3 and other 
cyclic polymers. Hp 2-1 is also heterogeneous, but composed of simple homodimer 
(α1β)2, a linear trimeric αβ chain (αβ)3, and other linear polymers; where α represents 
a mixture of α1 and α2 chains. All types share a common structure of the β chain 
(Cheng et al., 2007).  
 
 
1.4.1.2. Sites of production  
 
Haptoglobin is mainly produced by the liver and secreted into the serum. Besides blood 
serum, Hp is found in bovine milk (Hiss et al., 2004), in human cord serum, cerebrospinal 
fluid, amniotic and vaginal fluids (Katnik and Dobryszycka, 1990), and in porcine saliva 
(Hiss et al., 2003). Haptoglobin messenger ribonucleic acid (mRNA) expression has been 
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reported under normal and inflammatory conditions in a variety of organs and tissues of mice 
including lungs, skin, spleen and kidneys (D’Armiento et al., 1997), adrenal gland, ovary and 
uterus (Friedrichs et al., 1995). For cattle, Hp mRNA is reportedly expressed in mammary 
gland (Hiss et al., 2004; Thielen et al., 2005), oviduct and liver (Lavery et al., 2004), and 
leukocytes (Thielen et al., 2005). There is a growing body of evidence indicating that Hp 
mRNA is expressed in AT. It was suggested that Hp is also involved in obesity because its 
serum concentrations are increased in obese humans (Chiellini et al., 2004), and this is 
consistent with the concept that obesity is a state of chronic mild inflammation (do 
Nascimento et al., 2004). In this regard, Friedrichs et al. (1995), Chiellini et al. (2002) and do 
Nascimento et al. (2004) reported that Hp gene is expressed in AT in normal and obese mice. 
Similarly, Hp gene expression has also been identified in human AT (do Nascimento et al., 
2004). The above mentioned authors concluded that Hp synthesis occurs in adipocytes rather 
than in other cell types within AT. Moreover, there are differences among the different AT 
depots in terms of Hp expression, i.e. VC depots release more Hp than SC depots in humans 
(Fain et al., 2004).  
 
1.4.1.3. Physiological functions  
 
The main function of Hp is binding Hb to prevent losses of iron via urine after haemolysis, 
thereby protecting tissues from being damaged by free Hb (Langlois et al., 1996; Petersen et 
al., 2004). The Hp-Hb complex has several other benefits: (1) it restricts the availability of 
iron necessary for bacterial growth, and thus inhibits bacterial activity (Delanghe et al., 1998); 
(2) it scavenges the Hb-driven free radicals (superoxide (O2-) and hydroxyl (OH)) during 
oxidative stress (Melamed-Frank et al., 2001); (3) it inhibits nitric oxide, which is a potent 
vasodilator molecule that is produced by vascular endothelial cells (Edwards et al., 1986); and 
(4) it inhibits eicosanoid (prostaglandin) synthesis (Komoriya et al., 1980), hence Hp is 
suggested as an anti-inflammatory agent. Haptoglobin also exhibits other activities. For 
instance, Hp has been identified as a strong angiogenic agent required for proliferation and 
differentiation of endothelial cells in the formation of new blood vessels (Park et al., 2009), 
and as a modulator of the immune system, i.e. it inhibits the activation of neutrophils (Oh et 
al., 1990). Haptoglobin in AT might act as a monocyte chemoattractant factor (Maffei et al., 
2009), and as an antioxidant or angiogenesis agent (do Nascimento et al., 2009). 
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1.4.1.4. Haptoglobin as an indicator for health status 
 
In cattle and other ruminants, Hp is suggested as a marker of inflammation. In healthy cattle, 
Hp blood concentrations are low or even undetectable (Eckersall et al., 2001), but increase 
over 1000-fold (Eckersall et al., 2006) upon immune stimulation. For milk, a 160-fold 
increase in Hp concentrations has been observed after intramammary challenge with 
lipopolysaccharide (Hiss et al., 2004). Several studies have indicated the significance of Hp in 
serum for identifying the occurrence and severity of inflammatory responses such as mastitis 
(Eckersall et al., 2006; Hiss et al., 2007), and metritis (Chan et al., 2004; Huzzey et al., 2009). 
Elevated Hp concentrations occur with some conditions not generally associated with 
inflammation or tissue damage such as fatty liver (Nakagawa et al., 1997), and stress 
associated with transportation for 2 days (Murata and Miyamoto, 1993). Elevated Hp 
concentrations were also observed after surgical castration in bull calves (Fisher et al., 2001), 
and tail docking in heifers (Eicher et al., 2000). Several studies have been conducted to define 
the cut-off values for serum Hp to discriminate between healthy and diseased animals. In this 
regard, a cut-off value for serum Hp of 0.15 mg/mL was defined in dairy heifer calves with 
respiratory-tract disease, whereby sensitivity and specificity were 72% and 59%, respectively 
(Svensson et al., 2007). A cut-off value of 0.05 mg/mL was used to differentiate between 
healthy cows and those with mastitis, whereby sensitivity and specificity were 83% and 90%, 
respectively (Eckersall et al., 2001). In milk, to distinguish between healthy quarters and 
those with subclinical mastitis a cut-off value of 2.2 µg/mL was determined by Hiss et al. 
(2007), whereby sensitivity and specificity were 85% and 92%, respectively.  
 
1.5. Leptin 
 
1.5.1. Structure 
 
The product of the obese gene (ob), which was discovered in the mid-1990s by Zhang et al. 
(1994), was named leptin (derived from the Greek term leptos meaning thin). Leptin, a 16-
kDa protein consisting of 146 amino acids is released into the blood after cleavage of the 21 
amino acid signal peptide (Zhang et al., 1994). Leptin is a four-helix protein and contains a 
short helical segment (Fig. 2), which is similar to the structure of the cytokine-family (Zhang 
et al., 1997). Leptin contains one single disulfide bond that links two cysteines (Fig. 2), and 
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this bond has been proven critical for the structural integrity and stability of leptin (Rock et 
al., 1996).  
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2. Ribbon diagram of the ob protein. The view is perpendicular to the four helical 
bundle axis (A, B, C and D), the additional short helical segment (E), and the 
connecting loops AB, BC and CD. The N and C terminal are indicated. The 
disulphide bridge between the C-terminal Cys 146 and Cys 96 in the AB loop is 
represented with ball-and-stick model (Zhang et al., 1997; Liefers, 2004). 
 
1.5.2. Occurrence and sites of production 
 
Leptin is an adipose-derived hormone that regulates a wide variety of physiological processes 
including appetite and EB, and it is also involved in the regulation of reproduction, 
neuroendocrine and immune function (Ahima and Flier, 2000; Ingvartsen and Boisclair, 
2001). Despite the evidence that leptin is produced mainly by adipocytes, other sites of it’s 
gene expression have been reported such as mammary gland (Casabiell et al., 1997), placental 
and fetal tissues (Masuzaki et al., 1997; Hoggard et al., 1998), stomach (Bado et al., 1998), 
muscles (Wang et al., 1998), hypothalamus and pituitary gland (Morash et al., 2000) and 
brown AT (Cinti et al., 1997). Leptin expression is influenced by the status of energy stores, 
but other metabolic and endocrine factors participate in regulating leptin production. Leptin 
synthesis is stimulated by obesity, insulin (Saladin et al., 1995), glucocorticoids (Slieker et al., 
1996), infection, endotoxins, cytokines (Grunfeld et al., 1996), glucose, lipids and estrogens 
(Wang et al., 1998), whereas it is inhibited by thyroid hormones (Escobar-Morreale et al., 
1997), fasting, cold, physical activity and testosterone (Castracane et al., 1998).  
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1.5.3. Role of leptin in food intake and body weight regulation  
 
Leptin is primarily produced in the AT as mentioned before, and acts via a family of 
membrane bound receptors. A total of six leptin receptor isoforms in different tissues was 
reported. One isoform with a long intracellular domain (ob-Rb) is predominantly expressed in 
the hypothalamic regions, and is involved in the regulation of food intake and energy 
homeostasis (Elmquist et al., 1998). Within the central nervous system (CNS), the 
hypothalamus is the main site of leptin action with respect to control food intake and energy 
expenditure (Ingvartsen and Boisclair, 2001). Therefore, leptin must enter the brain cavity to 
act on the CNS. Most of the plasma proteins enter the brain via the blood-cerebrospinal fluid 
barrier at the blood-brain barrier at the cerebral endothelium (Pardrige, 1998). Neuropeptide 
Y (NPY) is secreted by the hypothalamus and regulates food intake; leptin binds to ob-Rb 
receptors that are mainly localized on NPY neurons and thereby inhibits the signaling of 
NPY, resulting in a reduction of feed intake and an increase of energy expenditure (Jang et al., 
2000). Further, plasma leptin concentrations are affected by changes in the plane of nutrient 
supply. In sheep, feeding restricted to 39% of the maintenance energy requirements (MER) 
for 3 d (Delavaud et al., 2000), and to 38% of the MER for 14 weeks (Morrison et al., 2001) 
decreases plasma leptin concentrations. Complete food deprivation causes a rapid fall in 
plasma leptin within 24 h in sheep (Marie et al., 2001). In contrast, increasing the dietary 
intake from moderate to high in pregnant ewes and adult rams increases the concentrations of 
plasma leptin (Blache et al., 2000; Thomas et al., 2001). In humans and rodents, leptin is 
synthesized in proportion to the overall degree of adiposity (Friedman and Halaas, 1998). 
Similar relationships have been observed between leptin and body fatness in sheep (Blache et 
al., 2000; Thomas et al., 2001; Altmann et al., 2006), body condition score (BCS) (Ehrhardt et 
al., 2000; Delavaud et al., 2002) and adipocyte size in cows (Delavaud et al., 2002).  
 
1.5.4. Role of leptin in reproduction 
 
Leptin is involved in the regulation of reproductive functions; it stimulates the production of 
the gonadotropins (luteinizing hormone (LH) and follicle stimulating hormone (FSH)) from 
the hypophysis via gonadotrophin-releasing hormone (GnRH) neurons in the hypothalamus 
(Amstalden et al., 2003). Since leptin is involved in the regulation of food intake, body weight 
(BW) and reproductive function, it is an interesting hormone to be investigated during the 
periparturient period in dairy cattle when many changes take place both in energy metabolism 
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and reproductive physiology. During pregnancy, leptin concentrations are high, and then 
decline rapidly towards parturition (Holtenius et al., 2003; Hachenberg et al., 2007; Duske et 
al., 2009). These high concentrations of leptin during pregnancy are due to an increase in 
body fat reserves and a concomitant increase in leptin mRNA expression in AT (Ehrhardt et 
al., 2001). The decline in plasma leptin concentrations towards parturition with the onset of 
NEB is probably caused by the inhibition of leptin expression in AT (Block et al., 2001), and 
mobilization of AT (Liefers et al., 2005). Another reason is the regulation of leptin expression 
by insulin and GH. The onset of NEB around parturition is also associated with decreased 
plasma insulin and increased plasma GH (Block et al., 2003), suggesting that both hormones 
could mediate a portion of the effect of EB on plasma leptin. As mentioned before, leptin is 
involved in the regulation of immune function, therefore the reduction in leptin concentrations 
of early lactating cows could contribute to the development of depressed immunity as 
suggested in fasted mice that leptin has a specific effect on T lymphocyte responses, 
differentially regulating the proliferation of naive and memory T cells (Lord et al., 1998). 
Furthermore, leptin increases helper T-cell type 1 and suppresses helper T-cell type 2 
cytokine production (Lord et al., 1998). In addition, changes in leptin concentrations of early 
lactating cows could participate in the co-ordination of metabolism through promoting a faster 
increase in voluntary feed intake (Block et al., 2001; Holtenius et al., 2003).  
 
1.6. Nutritional considerations during the transition period 
 
Most of the attempts to improve the energy status and minimize the extent and the duration of 
NEB have been approached by increasing the energy density of the diet by feeding dietary fat 
sources and increasing non-fiber carbohydrates (e.g. grain-based supplements) (Grummer, 
2007). Supplemental fats have proven to be beneficial for improving energy intake and 
reducing an energy deficit in early lactation. Moreover, feeding supplemental fat could reduce 
FA mobilization from AT and potentially reduce the incidence of ketosis (Kronfeld, 1982), 
improve the reproductive efficiency (Staples et al., 1998), and modulate the immune reaction 
(Calder et al., 2008). In contrast, fat feeding can often result in a depression of DMI due to the 
effect of fat on ruminal fermentation and gut motility, the decrease of palatability and the 
increased rate of FA oxidation in the liver (Allen, 2000). Protecting FA from the degradation 
by rumen bacteria which will be mentioned later, makes them partially inert in the rumen and 
sometimes can prevent a depression in DMI (Jenkins and Palmquist, 1984). The duration 
(long- or short-term) of the exposure to the fat feeding, amount and type of FA differ among 
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studies. A new interest is directed to CLA, as one of the FA that play a role in the reduction of 
milk fat percentage during lactation in cows. The following section will provide the current 
knowledge about CLA and it’s interaction with Hp and leptin. 
 
1.6.1. Conjugated linoleic acids 
 
1.6.1.1. Structure, biological and commercial formation of conjugated linoleic acids  
 
Fatty acids are playing a central role in metabolism as energy storing units and major building 
blocks for cellular membranes. Linoleic acids (C18:2), the major FA in most oilseeds, and 
linolenic acid (C18:3), the major FA in fresh forages, are considered as essential FA because 
they cannot be synthesized by mammals or by ruminal microorganisms. Both are 
polyunsaturated fatty acids (PUFA) in that they have more than one double bond. Chilliard et 
al. (2000) proposed that 80% of dietary linoleic acids are biohydrogenated in rumen due to the 
toxicity of PUFA to many rumen microorganisms. One of the biohydrogenation intermediates 
is CLA. Conjugated linoleic acids refer to a group of PUFA that exist as positional and 
geometric isomers of linoleic acid (Gudbrandsen et al., 2009). The term conjugated pertains to 
the chemical bond system, in which two double bonds are linked by a single bond. Further, 
each of these positional conjugated diene isomers occurs in cis (c) or trans (t) configurations 
(Aydin, 2005). 
The existence of CLA is known since over 70 years. In 1935, it was observed that ultraviolet 
absorbance at 230 nm of milk fat increased when cattle were driven out to pasture in spring 
(Booth et al., 1935). However, the recent interest in CLA began with the isolation from meat 
as an anti-carcinogenic factor in mice and rats (Pariza and Hargraves, 1985). Nine different 
positional and geometric isomers of CLA are reported by Ha et al. (1989), whereby the (c-9, 
t-11), (t-10, c-12), (t-9, t-11) and (t-10, t-12) isomers account for more than 89% of total 
naturally occurring CLA, while the (c-9, c-11), (t-9, c-11), (c-10, c-12), (c-10, t-12) and (c-11, 
c-13) isomers are minor contributors. Of the isomers, the c-9, t-11 is the predominant natural 
CLA isomer derived mainly from ruminant meat and milk products (Raff et al., 2008). The 
chemical structures of linoleic acid, the c-9, t-11 and the t-10, c-12 isomers are shown in Fig. 
3. Food lipids from ruminants (dairy products, beef and lamb) contain considerably more 
CLA than lipids from non-ruminants. Concentrations in dairy products are variable and range 
from 3 to 9 mg/g fat (MacDonald, 2000). Beef contains 1 - 10 mg/g fat with slightly higher 
concentrations (4 - 19 mg/g fat) in lamb (Schmid et al., 2006). The concentrations in fats from 
non-ruminants and vegetable oils typically range from 0.6 to 0.9 mg/g fat (Chin et al., 1992). 
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Fig. 3. Structure of linoleic acid (top), c-9, t-11 CLA (mid) and t-10, c-12 CLA (bottom). 
Double bond positions are indicated by numbers (Aydin, 2005). 
 
 
Two pathways are contributing to CLA biosynthesis (Fig. 4). The first pathway is the 
formation of CLA during the ruminal biohydrogenation of linoleic acid, where the sequential 
reduction steps convert linoleic acid (C18:2 c-9, c-12) to the c-9, t-11 CLA, then to vaccenic 
acid (C18:1, t-11) and eventually to stearic acid (C18:0) by a rumen microorganism, i.e. by 
Butyrivibrio fibrisolvens (Bauman et al., 2000). The second synthetic pathway arises when the 
dietary supply of unsaturated FA is high, or the biohydrogenation process may be incomplete. 
Conjugated linoleic acid can then escape the rumen and become available for absorption in 
the lower digestive tract, thus providing a source of CLA to the mammary gland and AT 
through desaturation of C18:1, t-11 by ∆9-desaturase (Griinari and Bauman, 1999).  
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4. Role of rumen biohydrogenation and tissue ∆9-desaturase in the production of c-
9, t-11 conjugated linoleic acid in ruminant fat (Bauman et al., 2000). 
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The commercial CLA supplements are isomeric mixtures usually containing the t-10, c-12 
and the c-9, t-11 isomers in equal amounts. The CLA are commercially manufactured by: (1) 
alkali isomerization of linoleic acid (Yang et al., 2002); (2) dehydration of ricinoleic acid 
methyl ester (Body and Shorland, 1965); and (3) microbial synthesis of c-9, t-11 from linoleic 
acid using cultures of different microorganisms (Pariza and Yang, 1999). Several techniques 
are used to protect fat supplements from the degradation by rumen bacteria. These include the 
formation of calcium salts, amide linkages, formaldehyde treatment and lipid encapsulation 
(Moon et al., 2008). 
 
1.6.1.2. Physiological effects of conjugated linoleic acids  
 
A plethora of physiological effects in a wide range of experimental animals has been 
attributed to CLA including actions as an anti-adipogenic, anti-diabetogenic, anti-
carcinogenic, and anti-atherosclerotic factor (Belury, 2002; Wang and Jones, 2004). In 
addition, CLA affects the rate of bone formation as reported in rats (Li et al., 1999). The 
beneficial effects of CLA have been extended to include reduction in BW, food and energy 
intakes, and change in body composition, as well as beneficial regulatory effects on the 
immune functions. Moreover, CLA supplementation modulates lipid metabolism and leads to 
milk fat depression in lactating cows (Kay et al., 2007; Bauman et al., 2008). There appears to 
be an isomer-specific effect of CLA: the t-10, c-12 CLA isomer inhibits bovine milk fat 
synthesis (Baumgard et al., 2002). This isomer is much more effective at lowering BW and 
AT mass than the c-9, t-11 CLA isomer in mice (Park et al., 1999). On the other hand, 
adverse effects of CLA are described in some experimental animals such as inflammatory 
effects induced by the t-10, c-12 CLA isomer (Poirier et al., 2006), increased fat accumulation 
in the liver and eventual development of insulin resistance using an equimolar mixture of c-9, 
t-11 and t-10, c-12 CLA isomer (Tsuboyama-Kasaoka et al., 2000). Special emphasis in the 
up-coming sections will be given on the effect of CLA on BW and body composition as well 
as the immune modulatory functions of CLA.  
 
Feeding a mixture of CLA isomers has been reported to reduce BW gain in rats (Ryder et al., 
2001) and mice (Park et al., 1999). These studies illustrate that the reduction in BW is due to 
the action of the t-10, c-12 CLA isomer, whereas others observed no effect on BW (Yamasaki 
et al., 2003). The ability of CLA to lower AT mass by reducing the accumulation of 
triglycerides in adipocytes has been demonstrated in humans (Smedman and Vessby, 2001; 
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Thom et al., 2001), mice (DeLany et al., 1999), and pigs (Ostrowska et al., 1999). 
Furthermore, CLA induced a reduction in adipocyte size in rats (Poulos et al., 2001), mice 
(Tsuboyama-Kasaoka et al., 2000), and in dairy cows (Akter et al., 2011). Also, CLA has 
been reported to modulate adipokine production. For example, circulating leptin is reduced in 
rats fed 2% CLA (by diet weight; mixed isomers) for 12 weeks (Yamasaki et al., 2000), 1.5% 
CLA of the diet for 3 weeks (Yamasaki et al., 2003), and 1% CLA (of the diet weight) mixed 
isomers for 4 weeks (Rahman et al., 2001). Moreover, Parra et al. (2010) reported that when 
mice received two doses of 3 and 10 mg/d CLA (50:50 blend of c-9, t-11 and t-10, c-12 
isomers) for 30 days and twice the amounts for another 35 days, leptin concentrations were 
decreased with increasing the CLA dose associated with reductions in fat accumulation, 
NEFA and adiponectin. In humans, 3 g/d CLA (mixed isomers) for 64 days cause a reduction 
in leptin concentrations without any remarkable change in fat mass (Medina et al., 2000). 
Conversely, several studies reported that dietary CLA supplementation had no effect on leptin 
concentrations in beef heifers fed 2% (of total ration on dry matter (DM) basis) rumen-
protected CLA salts (a mixture of Ca-salts of palm oil FA with 31% CLA (27.2% c-9, t-11; 
32.8% t-10, c-12; 10.6% t-8, c-10; 18.95% c-11, t-13 and 10.5% various t, t CLA isomers)) on 
the last 32 or 60 days before slaughter (Gillis et al., 2004b), and in dairy cattle in mid to late 
lactation receiving 10 g/d abomasal infusions of either c-9, t-11 or t-10, c-12 CLA isomer for 
5 days (Baumgard et al., 2002). 
 
The mechanisms by which the CLA reduce adiposity are not only attributed to the reduction 
in food and energy intakes, but also involve other pathways including increasing the 
metabolic rate, energy expenditure, lipolysis and fat oxidation, and decreasing lipogenesis 
(Wang and Jones, 2004). Peroxisome-proliferator-activated receptors (PPAR) are a group of 
nuclear receptor proteins that function as transcription factors regulating the expression of 
genes and playing essential roles in the regulation of cellular differentiation, inflammation 
and metabolism (Kersten, 2002). Three different PPAR isotypes were identified: α, β and γ. 
However, the reasons for the effect of CLA on leptin could be that CLA act as a ligand that 
activates PPARγ (Medina et al., 2000), which might then reduce leptin gene expression. 
Conjugated linoleic acids are incorporated into the phospholipid fraction of cell membrane 
and might thereby have effects on signal transducing pathways and modify leptin production 
(Medina et al., 2000).  
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Fig. 5. Schematic diagram of putative cellular and molecular mechanisms of conjugated 
linoleic acids in modulating systemic conditions such as adiposity and 
inflammation (Belury, 2002). Abbreviations: COX = cyclooxygenase, LOX = lipoxygenase, 
PPRE = peroxisome proliferator response element, RXR = retinoid X receptor, 9CisRA = retinoic acid, 
n = α, β, γ. 
 
Fatty acids are important modulators of the immune system (Calder, 2008; Serhan et al., 
2008). In a number of different animals, CLA has been suggested to have anti-inflammatory 
and/or immune-ameliorating effects mediated partly by PPARγ (Yu et al., 2002). One of the 
perceived mechanisms by which CLA exerts its health effects in animals is through 
modulating the formation of eicosanoids through cyclooxygenase (COX) and lipoxygenase 
(LOX) pathways (Fig. 5), thus exerting a complex control mainly in inflammation and 
regulation of cytokine synthesis (Belury, 2002). Aspects of both the innate and the adaptive 
immune responses are affected by dietary CLA supplementation. O’Shea et al. (2004) 
reported that CLA decreased TNF-α and IL-6, and the c-9, t-11 and t-10, c-12 CLA isomers 
exerted distinct effects on T cell populations and immunoglobulin subclasses in rats. 
However, there is limited supporting information about the effect of CLA on APPs. In this 
regard, Noto et al. (2007) showed that rats fed 1.5% (1.5 g/100 g of total ration) CLA isomers 
(t-10, c-12; c-9, t-11; c-11, t-13 and t-8, c-10) for 8 weeks had lower serum Hp concentrations 
and adipose TNF-α mRNA, but no difference in liver Hp mRNA abundance was detected. 
However, on other inflammation markers, it has been shown that 3.4 g/d CLA (purified t-10, 
c-12) in men with metabolic syndrome for 12 weeks increase significantly CRP (2.2-fold), but 
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no significant increase was found for TNF-α and IL-6 (Risérus et al., 2002). In non obese 
humans, 3.2 g/d CLA (equal amounts of c-9, t-11 and t-10, c-12 isomers) for 12 weeks 
increased CRP, but CLA supplementation did not have any significant effect with regard to 
plasma concentrations of TNF-α (Smedman et al., 2005). In contrast, Moloney et al. (2004) 
found no effect of 3 g/d CLA (50:50 blend of c-9, t-11 and t-10, c-12) supplemented for 8 
weeks on CRP or IL-6 in humans. 
 
1.7. Study objectives  
 
Considering the immuno-compromised situation in early lactation and the comprehensive 
changes in fat mass during the lactation cycle of dairy cows, management of the transition 
cows emerged to underpin production and profitability on dairy farms. However, in dairy 
cows CLA is known to decrease milk fat percentage during lactation and decrease energy 
output during early lactation. It is still unknown if long-term nutritional supplementation with 
CLA could stimulate or inhibit the expression of the inflammatory response and adipokines, 
particularly in ruminant animals. Although Hp has been extensively studied under various 
inflammatory and non-inflammatory conditions, the effect of long-term CLA supplementation 
on this protein has not yet been investigated. The liver is reported as the main site of Hp 
production, but other sites of production were proved such as AT in humans and mice, but, 
however, less is known in ruminants. Researches on how long-term CLA supplementation 
may alter circulating leptin concentrations are limited. Finally, as early lactating cows 
mobilize AT under conditions of NEB, the initial step in non-lactating cows to overcome the 
energy deficit is the mobilization of an excessive quantity of AT. Thus, the question arises if 
there is any change in the concentrations of Hp and leptin in non-lactating, non-pregnant cows 
undergoing fat mobilization.  
Bearing in mind the above mentioned circumstances, the current study was undertaken to:  
1. Characterize the concentrations of Hp and leptin throughout the entire lactation period or 
early lactation in both heifers and cows.  
2. Investigate the potential effect of long-term CLA supplementation on the concentrations of 
Hp and leptin in dairy cows. 
3. Examine the presence of Hp in bovine AT using immunohistochemistry (IHC) and Western 
immunoblotting. 
4. Examine the effect of moderate feed restriction and re-feeding on the concentrations of Hp 
and leptin in non-lactating, non-pregnant heifers. 
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2. Materials and methods 
 
2.1. Animals, experiments and diets  
 
Samples from four different studies were used in this work. The first experiment was 
conducted to characterize the concentrations of Hp and leptin throughout lactation and to 
evaluate the effects of two different doses of CLA supplementation. This experiment 
comprised heifers and cows observed from d 21 ante partum (AP) until d 252 post partum 
(PP) and was named “CLA-252 days in milk (DIM)”. In addition, a further experiment using 
a CLA supplementation was done in heifers investigated from d 21 AP until d 105 PP. In this 
experiment, the animals were sequentially slaughtered for collection of post mortem (PM) 
tissue samples. This experiment was termed “CLA-PM-105 DIM”. The third experiment 
“Concentrate-roughage ratio” was conducted (d 21 AP - d 21 PP) using cows fed either low 
or high concentrate. A fourth experiment “Fat heifers restriction” using non-lactating, non-
pregnant heifers fed either grass silage or grass silage diluted with straw was performed to 
examine the effect of moderate feed restriction and re-feeding on the concentrations of Hp 
and leptin. The ingredients and chemical composition of the animals’ diets in the different 
studies are listed in the appendix A (Tab. A1 - A7). 
 
2.1.1. Conjugated linoleic acid studies 
 
All animals’ experiments were conducted according to the European Union regulations and 
were approved by the lower saxony state office for consumer protection and food safety 
(LAVES, file number 33.11.42502-04-071/07, Oldenburg, Germany), and described in detail 
by Pappritz et al. (2011) and von Soosten et al. (2011). All animals were housed in group pens 
in a free stall barn equipped with slatted floors and stalls covered with rubber mattresses at the 
experimental station of the Friedrich Loeffler Institute, Federal Research Institute for Animal 
Health, Braunschweig, Germany. Each group pen was equipped with a computerized 
concentrate and a partial mixed ration (PMR) feeding station (Type RIC, Insentec, B.V., 
Marknesse, The Netherlands). In addition, all animals were marked with an ear transponder to 
record the daily individual feed intake. Two experiments were performed; the CLA-252 DIM 
and the CLA-PM-105 DIM experiments, and all diets used were formulated according to the 
recommendation of the German Society of Nutrition Physiology (GfE, 2001). The BCS of 
each animal was recorded by using a five-point system (Edmonson et al., 1989). Milking took 
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place twice daily and the BW was automatically recorded when leaving the milking parlour. 
The occurred disease events were recorded during milking by the milking staff or during the 
daily animals control by the stockmen and/or the veterinarian, and when indicated, the 
animals were attended by the veterinarian. Abnormal vaginal discharges were classified as 
metritis. Cows with clinical mastitis were identified by farm personnel based on the presence 
of abnormal milk (presence of flakes, clots or altered color and viscosity). The somatic cell 
count (SCC) was measured by infrared milk analyzer (Milkoscan FT 6000 combined with a 
Fossomatic 5000, Foss Electric, Hillerod, Denmark) (von Soosten et al., 2011). The disease 
incidence rate was defined as the number of disease event cases divided by the total number 
of animals during the observation period according to Kelton et al. (1998). 
 
2.1.1.1. CLA-252 DIM experiment 
 
2.1.1.1.1. Treatments and diets 
 
German Holstein-Friesian cows (n = 33) and heifers (n = 16) were investigated from d 21 AP 
until d 252 of the subsequent lactation. The animals were randomly allocated to three dietary 
treatments taking into account the mean number of lactation (1.9 ± 0.1), the live weight (627 
± 9 kg), and the milk yield of the previous lactation (5,797 ± 122 kg, 200-d milk yield) for the 
cows. The dietary treatments were: (1) 100 g/d of control fat supplement (Silafat, BASF SE, 
Ludwigshafen, Germany; CTR: 11 cows and 5 heifers); (2) 50 g/d of rumen-protected 
commercial CLA supplement (lipid encapsulation method; Lutrell Pure, BASF SE, 
Ludwigshafen, Germany; CLA-50: 11 cows and 6 heifers) and 50 g/d of CTR fat supplement; 
and (3) 100 g/d of CLA (CLA-100: 11 cows and 5 heifers). The CLA supplementation started 
on d 1 PP and lasted until d 182 PP. In the AP period, all animals were received a diet 
consisting of PMR (40% grass silage (5.4 MJ NEL/kg) and 60% corn silage (6.4 MJ NEL/kg))  
on DM basis as ad libitum consumption and 2 kg/d concentrate (6.7 MJ NEL/kg) from the 
computerized concentrate feeding station (Tab. A1). During the supplementation period, the 
animals were fed PMR (6.8 MJ NEL/kg) ad libitum consisting of 63% silage and 37% 
concentrate on DM basis, and additionally each animal received 4 kg concentrate (8.8 MJ 
NEL/kg) from the concentrate station containing either 50 or 100 g/d of CLA supplement and 
50 g of CTR fat supplement (Tab. A2; Pappritz et al., 2011). During the post-treatment period 
(d 189 - 252 PP), the animals received only PMR without concentrate. The CLA supplement 
included 78% FA with a proportion of approximately 12% of the t-10, c-12 and c-9, t-11 CLA 
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isomers in equal parts. In the CTR fat supplement, these isomers were substituted by a 
corresponding amount of stearic acid (C18:0). The FA profiles for both of CLA and CTR fat 
supplements are shown in Tab. A3 (Pappritz et al., 2011; von Soosten et al., 2011). The 
concentration of the t-10, c-12 CLA isomer in concentrates and silages was calculated based 
on the analyzed concentrations in these feed components. In the CLA concentrate, the 
concentration of the t-10, c-12 CLA isomer amounted to 2.25 g/kg DM (Tab. A2; Pappritz et 
al., 2011). Thus, the CLA-50 and CLA-100 groups had intakes of 4 and 8 g of t-10, c-12 
CLA/d, respectively.  
 
2.1.1.1.2. Blood collection 
 
Blood samples were drawn from the Vena jugularis externa on d –21, –14, –7, 1, 7, 14, 21, 
35, 49, 70, 105, 140, 182, 189, 196, 210, 224, 238, and 252 relative to parturition as shown in 
Fig. 6. The centrifugation of serum was performed after sampling, and the samples were 
stored at –80°C until analyzed (Pappritz et al., 2011).   
 
 
 
 
 
Fig. 6. Diagram of the experimental design and blood collection for the CLA-252 DIM 
experiment. 
 
2.1.1.2. CLA-PM-105 DIM experiment 
 
2.1.1.2.1. Treatments and diets 
 
German Holstein-Friesian heifers (n = 25) with an average age at first parturition of 23 ± 0.2 
months were used. The experiment started on d 21 AP and continued until d 105 PP. Before 
parturition, the heifers were kept in group pens and fed ad libitum with PMR (6.7 MJ NEL/kg) 
comprising of 60% corn silage and 40% grass silage as well as 2 kg concentrate (6.7 MJ 
NEL/kg) (Tab. A4; von Soosten et al., 2011). The heifers, which received the CTR (Silafat) or 
CLA (Lutrell Pure) after parturition, were housed in two group pens according to their diet. 
The PMR fed during the PP consisted of 25% grass silage, 38% corn silage and 37% PMR-
concentrate on a DM basis. In addition, 4 kg concentrate containing the CTR fat or CLA 
supplements (100 g/d each) were fed (Tab. A5; von Soosten et al., 2011). The CLA 
CLA supplementation 
  -21    -7      7      21    35     49      63     77    91    105   119  133  147   161   175   189   203   217   231  245   
Day of  
blood  
collection 
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supplementation started on d 1 PP and continued until slaughter. On the day of parturition, 5 
animals were slaughtered for determining the body composition and the weight of various 
organs as well as for collecting samples from SC and VC fat depots. The remaining 20 heifers 
were randomly allocated to either CTR fat supplement (100 g/d, n = 10) or CLA supplement 
(100 g/d, n = 10). Five animals each of the CTR and CLA group were then slaughtered on d 
42 PP and on d 105 PP. The FA profiles for both of CLA and CTR fat supplements are shown 
in Tab. A3 (Pappritz et al., 2011; von Soosten et al., 2011). The CLA concentrate contained 
1.7% of the t-10, c-12 and 1.6% of the c-9, t-11 CLA isomers (Tab. A5; von Soosten et al., 
2011). The heifers of the CLA group consumed 6 g/d and 5.7 g/d of the t-10, c-12 and c-9, t-
11 CLA isomers, respectively.  
 
2.1.1.2.2. Sample collection  
 
Samples of blood, milk and AT were collected for the CLA-PM-105 DIM experiment as 
demonstrated in Fig. 7. Blood samples were collected from the vena jugularis externa on d –
21, –14, –7, –3, 1 (n = 25), 7, 14, 21, 28, 42 (n = 20) and 105 (n = 10) relative to parturition. 
The centrifugation of serum was performed after sampling, and the samples were stored at –
80°C until analyzed (von Soosten et al., 2011). Milk samples were collected from each 
quarter of the 25 heifers on the respective slaughter days (d 1, 42 and 105) during the morning 
milking. After stunning and exsanguination, AT from 3 SC depots (tailhead, withers and 
sternum) and 3 VC depots (omental, mesenteric and retroperitoneal) were sampled and 
immediately fixed in 4% paraformaldehyde overnight. All AT depots were then dissected and 
weighted.  
 
 
 
 
 
 
 
 
 
 
Fig. 7. Diagram of the experimental design and sample collection for the CLA-PM-105 
DIM experiment. n: number of animals. 
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2.1.2. The concentrate-roughage ratio study  
 
2.1.2.1. Treatments and diets 
 
All animals were housed in a free stall barn at the experimental station of the Friedrich 
Loeffler Institute, Federal Research Institute for Animal Health, Braunschweig, Germany. The 
experimental design is described in detail by Locher et al. (2011). In brief, German Holstein 
dairy cows (n = 20) with a mean lactation number of 2.7 ± 0.18 were investigated from d 21 
AP until d 21 PP. The cows were randomly allocated to two dietary treatments after calving. 
The first treatment was a low concentrate diet (LC, n = 10), in which the animals were fed as 
a total mixed ration (TMR) consisting of 30% concentrate (8.3 MJ NEL/kg) and 70% 
roughage based on DM content. The second treatment was a high concentrate diet (HC, n = 
10), in which the animals were fed a TMR consisting of 60% concentrate (8.2 MJ NEL/kg) 
and 40% roughage. The feed ingredients and chemical composition of the PP diet are shown 
in Tab. A6 (Locher et al., 2011). During the experiment, no clinically relevant health 
problems occurred. Treatments were conducted according to the European Union regulations 
and were approved by LAVES, Germany (file number 33.14-42502-04-085/09). 
 
2.1.2.2. Blood collection 
 
Blood samples were harvested on d –21, –14, –7, –3, 1, 7, 14 and 21 relative to parturition. 
After centrifugation (10 min, 2,000 g), the serum was stored at –80°C until analyzed.  
 
2.1.3. The fat heifers restriction study  
 
2.1.3.1. Treatments and diets 
 
The animal experiment was approved by the North Rhine-Westphalian State Agency for 
Nature, Environment and Consumer Protection (LANUV-NRW, file number 
8.87.51.05.20.10.103, Recklinghausen, Germany). Twelve non-lactating, non-pregnant 
Simmental heifers with a mean BCS of 5 were housed in a tie stall barn at the research farm at 
Frankenforst, University of Bonn, Germany. The heifers were fed according to the 
recommendation of the German Society of Nutrition Physiology (GfE, 2001). The heifers (n = 
12), with an initial live weight of 692 ± 43.1 kg, were allocated to two different treatments 
(Fig. 8). During the adaptation period, which lasted for three weeks, all heifers received grass 
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silage (9.5 MJ/kg DM) ad libitum. After the adaptation period, the heifers were either 
continuously fed with grass silage as before (100%; n = 6), or were restricted to grass silage 
diluted with straw (hay/silage: straw mixture (8.1 MJ/kg DM) (37:63); n = 6) for 4 weeks. 
Thereafter, all animals received again the grass silage for further 3 weeks. The chemical 
composition of the diet is shown in Tab. A7. 
 
For synchronizing the heifers’ estrous cycle, progesterone-releasing intravaginal device 
(PRID®alpha, Ceva Sante Animale, Liboure, France) were inserted 12 days before the onset 
of the experiment, and were replaced regularly every 3 weeks. In addition, 2 mL 
prostaglandin (Estrumate®, Intervet, Unterschleißheim, Germany) were injected in each 
animal at the first day of progesterone-releasing intravaginal device insertion. The heifers’ 
weight was recorded at the beginning of the experiment and one day before or on each day of 
fat biopsy sampling as shown in Fig. 8.  
 
 
 
 
 
 
 
 
Fig. 8. Diagram of the experimental design and sample collection for the fat heifers 
restriction study. n: number of animals. 
 
2.1.3.2. Sample collection 
 
Blood samples were weekly collected from the coccygeal vein starting from the differential 
feeding period (Fig. 8). After centrifugation (20 min, 1,200 g, 4°C), the serum was stored at –
20°C until analyzed. Biopsy samples from SC tailhead were collected from each heifer on the 
0, 4th and 7th week (Fig. 8).  
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2.2. Laboratory analyses 
 
All chemicals, buffers and solutions used in the laboratory analyses are listed in the appendix 
C. 
 
2.2.1. Haptoglobin 
 
Haptoglobin was detected by using the following methods: an enzyme-linked immunosorbent 
assay (ELISA), immunohistochemistry (IHC) and Western immunoblotting.  
 
2.2.1.1. Measurement of haptoglobin in blood and milk by enzyme-linked 
immunosorbent assay 
 
A competitive ELISA as described by Hiss et al. (2004) was used. The assay was modified by 
Hiss et al. (2009) using a standard serum for coating the plates and for the calibration curve 
instead of Hp purified from bovine serum. The serum which was used as standard had been 
calibrated against a standard obtained from the European Union Concerted Action on the 
standardization of animal APP (QLK5-CT-1999-0153; Skinner, 2001). The limit of detection 
was 0.07 µg/mL, and the intra- and interassay coefficients of variation (CV) were 3.8% and 
5.6%, respectively. For performing the ELISA, 96 well-microtiter plates (EIA plate 9018, 
Corning Coster, Cambridge, MA) were coated with the calibrated bovine serum (dilution 
1:3,000 in coating buffer) at 4°C for 20 h. After blocking with 250 µL of 2.5% casein solution 
at room temperature (RT) for 2 h, the plates were washed 5 times with washing buffer by 
using a microtiter plate auto washer (EL405; Bio-Tek Instruments, Inc., Winooski, VT, USA), 
and stored at –20°C prior to use. To start the test, 50 µL of the standard solution at serial 
dilutions of 0.012, 0.037, 0.11, 0.33, 1, 3 and 9 µg/mL were added in duplicate. The controls 
with known concentration of Hp were added to the plate in duplicate. The samples with 50 µL 
volume were added in duplicate. Fifty µL of the antiserum (polyclonal rabbit antiserum 
against bovine Hp (dilution 1:100,000 in test buffer)) were then added and incubated for 2 h 
on a shaker (M-1000; Med Tec, New Bern, NC, USA) at RT. After 3 washes, 100 µL of the 
second antibody (goat anti-rabbit IgG coupled with horseradish peroxidase (HRP) (Sigma-
Aldrich Chemie, Taufkirchen, Germany, dilution 1:400,000 in test buffer)) were added and 
incubated for 30 min in a dark place. After 5 washes, the wells were filled with 140 µL of 
substrate solution and incubated in a dark place. The reaction was stopped after 30 min with 
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50 µL of 1 M oxalic acid, and the optical density (OD) was determined at 450 nm with a 
microplate reader (EL800; Bio-Tek Instruments). The concentrations of Hp in the samples 
were calculated from the calibration curve using the 4-parameter method of the Gen5TM data 
analysis software (Bio-Tek Instruments).  
 
2.2.1.2. Detection of haptoglobin in adipose tissue by immunohistochemistry 
 
The AT samples from the CLA-PM-105 DIM experiment were immediately fixed overnight 
in 4% paraformaldehyde (Roth, Karlsruhe, Germany, in phosphate buffered saline (PBS), pH 
7.4), dehydrated in ascending grades of isopropanol (Roth)) (40%, 70%, 80%, 96%, and 2 
times 100%), cleared in Roti®-Histol (Roth), and infiltered with a mixture of Roti®-Histol and 
melted paraffin (1:1, vol/vol) at 60°C. Finally, the samples were embedded in paraffin wax. 
The samples were cooled with Cryo-spray (Roth), sections (10 µm) were cut using a rotation 
microtome (SLEE, Mainz, Germany), mounted on SuperFrost®plus slides (Menzel, 
Braunschweig, Germany), dried at 60°C for 2 h, and hereafter at 37°C overnight. Sections 
were deparaffinized in Roti®-Histol, then gradually rehydrated in descending grades of 
isopropanol (100% (2 times), 96%, 80%, 70%, and 40%), and washed with distilled water. 
Antigen retrieval was performed with citrate buffer (0.01 mM pH 6) in a microwave oven for 
3 x 5 min at 700 W, and then the sections were allowed to cool at RT for 30 min, and washed 
with distilled water. The elimination of endogenous peroxidase activity was done using 3% 
H2O2 for 15 min, the sections were washed 3 x 5 min with PBS (pH 7.2, 0.05% Tween®-20), 
and the unspecific binding was blocked with normal goat serum (1:10) for 20 min. Thereafter, 
the sections were incubated with a polyclonal rabbit antiserum against bovine Hp (Hiss et al., 
2004; 1:2,000, in PBS) for 15 h. The sections were subsequently incubated with goat anti-
rabbit IgG coupled with HRP (1:200 in PBS) for 30 min. The sections were then stained with 
3-amino-9-ethylcarbazole (Biozol, Eching, Germany) as a substrate and counterstained in 
Mayer’s Haematoxylin (Merck Eurolab GmbH, Darmstadt, Germany). After rinsing with tap 
water for 10 min, the sections were mounted with Kaiser’s glycerol gelatin (Merck Eurolab 
GmbH). Based on previous findings that Hp mRNA is expressed in bovine leukocytes 
(Thielen et al., 2005), bovine lymph nodes were used as positive and negative controls 
(sections’ thickness: 6 µm). For negative controls, the primary antibody was replaced with 
non-immune rabbit serum. The sections were evaluated through a Leica DMLB microscope 
(Leica Microsystems, Wetzlar, Germany) at 200x magnification and photographed with a 
digital camera (JVC, Hachioji Plant of Victor Company, Tokyo, Japan). Positive cells were 
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counted within the boundaries of 10 random microscopic fields per section using DISKUS 
software (Hilgers, Königswinter, Germany), and the percentage of positive cells was 
calculated as the number of positive cells/total number of cells x 100. 
 
2.2.1.3. Detection of haptoglobin by Western immunoblotting 
 
Homogenates from fat (n = 1) and liver (n = 1) tissue samples from the CLA-PM-105 DIM 
experiment were prepared by chopping the frozen sections into small pieces. Then, the tissues 
(0.6 to 0.7 g) were transferred to Precellys®-tubes pre-filled with 1.4 mm ceramic beads 
(peQLab Biotechnology, Erlangen, Germany). Thereafter, the tubes were filled with 900 and 
600 µL of the homogenization buffer at pH 7.4 (10 mM HEPES, Applichem, Darmstadt, 
Germany) for the liver and fat tissue samples, respectively. The samples were homogenized 2 
times for 15 sec using a Precellys®24 homogenizer (peQLab Biotechnology). Afterwards, a 
protease inhibitor (CompleteTM, Roche, Mannheim, Germany) was added (45 µL/900 µL 
homogenization buffer for liver and 30 µL/600 µL homogenization buffer for fat), the 
homogenates were then vortexed, and finally centrifuged (10 min, 14,000 g). The supernatant 
was re-centrifuged (10 min, 14,000 g, 4°C), and the resulting supernant was then frozen at –
80°C.  
 
The Western immunoblotting analysis of Hp was performed as described by Hiss et al. 
(2004). The homogenized SC tailhead and liver tissue (10 µg/lane) as well as one bovine 
serum sample (1:200 in H2O) were each mixed with 1 µL dithiothreitol (5 M DTT, 
Applichem) and 10 µL sample buffer (5-fold, 20% sodium dodecyl sulfate (SDS)), boiled at 
95.7°C for 8 min and centrifuged (5 min, 10,000 g). The biotinylated molecular weight 
marker (RPN 2107, GE Health Care, Amersham, Buckinghamshire, UK) (5 µg/lane) was 
used, and boiled at 97.5°C for 8 min. The marker and samples were loaded on 5.6% stacking 
gel and separated using 12% resolving gel of acrylamide (Roth). The SDS polyacrylamide gel 
electrophoresis (PAGE) was performed starting with 50 V for 30 min, and then followed by 
150 V (Hoefer®pharmacia, Biotech, Inc., San Francisco, CA, USA).  
 
Polyvinylidene fluoride (PVDF) membranes (HybondTM-P, GE Health Care) were activated 
with methanol (10 sec), washed with distilled water (5 min), and finally embedded with 
blotting buffer II (10 min). Ten filter papers were used, in which 3 of them were incubated 
with blotting buffer I (pH 10.4, 0.3 M Tris/HCl, 10% methanol), 2 papers with blotting buffer 
II (pH 10.4, 25 M Tris/HCl, 10% methanol), and the other 5 papers with blotting buffer III 
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(pH 9.4, 25 M Tris/HCl, 10% methanol). The resolving gel was equilibrated with blotting 
buffer II (10 min). Then the filters, membranes and the resolving gel were all sequentially 
placed in a semi-dry Electro-Blotter (STARLAB, Ahrensburg, Germany). The proteins were 
electrically transferred from the gel to the membrane for 30 min (30 mA).  
 
Thereafter, the membranes were blocked with Roti®block (Roth) (diluted 1:10 in TBST (Tris-
Buffered Saline, 0.05% Tween®-20)) on the shaker (10 rpm) for 1 h. The membranes were 
incubated with the polyclonal rabbit antiserum against bovine Hp (diluted 1:240,000 in 
Roti®block with TBST) on the shaker (10 rpm) for 1 h. Then, the membranes were washed 4 
x 5 min with TBST, and incubated with the goat anti-rabbit IgG coupled with HRP (diluted 
1:250,000 in Roti®block with TBST) on the shaker (10 rpm) for 1 h. The incubation with 
streptavidin-peroxidase (diluted 1:700,000 in Roti®block with TBST) was performed on the 
shaker (10 rpm) for 1 h after washing 4 x 5 min with TBST. The membranes were washed 4 x 
5 min with TBST, placed in a plastic bag, and incubated with a mixture of equal volumes of 
each the enhanced chemiluminescence detection kit solutions A and B (ECL; RPN 2135, GE 
Health Care) for 5 min in darkness. The surplus from the detection kit was removed, and the 
membranes were placed under a CL-XPosureTM Film (Thermo Scientific). Finally, the film 
was exposed for 2 to 5 min and developed immediately. The obtained bands were visually 
evaluated according to their molecular weight without a densitometric analysis due to the low 
number of samples (n = 2). 
 
2.2.2. Measurement of leptin in blood by enzyme-linked immunosorbent assay 
 
Analysis of serum leptin was performed using a competitive ELISA as published by 
Sauerwein et al. (2004). The limit of detection was 0.3 ng/ml, and the intra- and interassay 
CV were 3.8% and 9.3%, respectively. The microtiter plates were coated by incubating 150 
ng sheep 6 anti-rabbit-Fc fragment in the coating buffer with a volume of 100 µL/well at 4ºC 
for 20 h. After blocking the free binding sites with 200 µL of 2.5% casein solution at RT for 2 
h, the plates were washed 5 times, filled with 200 µL test buffer/well, and stored at 4ºC. For 
performing the assay, the plates were decanted and 50 µL of the antiserum (polyclonal rabbit 
anti-leptin, diluted 1:12,000 in test buffer) with test buffer containing 1% goose serum were 
added. The controls with known concentrations of leptin and the serial standard dilutions 
(Recombinant ovine leptin, 0.11, 0.33, 1, 3, 9 and 27 ng/mL) were each pipetted (50 µL) in 
duplicate into the wells. Fifty µL of serum samples (diluted 1:2.5 in test buffer) were added 
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into each well. After 5 min shaking (M-1000; Med Tec), the plates were incubated for 16 h at 
25ºC using a Thermostatic cabinet (Aqualytic®GmbH, Dortmund, Germany), where all 
further incubation steps were done. After the incubation, 50 µL of biotinylated recombinant 
leptin (Tracer, diluted 1:3,000 in test buffer) were added. After 2 h shaking with a shaker 
(MTS 4; IKA®SCHUTTER WERKE, Phoenix, AZ, USA, 250 rpm), the plates were decanted 
and washed 3 times, filled with 100 µL streptavidin-peroxidase (Southern Biotech, diluted 
1:15,000 in test buffer) and incubated for 45 min. After washing 5 times, the last incubation 
step was performed using 140 µL of substrate solution and incubated for 45 min. Then the 
reaction was stopped with 50 µL of 1 M oxalic acid. The OD was measured at 450 nm, and 
leptin concentrations were calculated as previously mentioned for the Hp ELISA.  
 
2.3. Statistical analyses 
 
All statistical analyses were performed using SPSS software, version 17.0 (SPSS, Inc., 
Chicago, IL, USA).  
 
For the CLA-252 DIM experiment, the mixed model procedure was used to analyze the data 
of serum Hp and leptin. Treatment (CTR, CLA-50 and CLA-100) was considered as a fixed 
factor, the sampling date (time) as a repeated effect and the respective interaction (time x 
treatment) was included into the model. The parity (cows vs. heifers) was considered as a 
fixed effect together with its interaction with the treatment. Parturition was considered via 
nested periods (before and after parturition) within time. For Hp, the clinical observations 
(diseased or not diseased) were considered in the model as a random effect for taking disease 
specific variations among groups into account. The covariance structure heterogeneous first-
order autoregressive initially tested, and the one with the lowest value of the Akaike’s 
information criterion was then applied. Comparisons among means were done using the 
Bonferroni test (P ≤ 0.05).  
 
For the CLA-PM-105 DIM experiment, where the repeated design was not applicable, all data 
were first tested for homogeneity of variances. In case of inhomogeneous variances, the non-
parametric Mann-Whitney test was used to compare the CTR vs. CLA group. Disease as a 
random effect for Hp was tested using the general linear model (GLM). For IHC data, the 
GLM was used to perform the comparisons within the CTR and the AT depots of both CTR 
and CLA treatments at P ≤ 0.05. To compare between the CTR and CLA treatments as well as 
between SC and VC depots, the student t-test was used and significant differences were 
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determined at P ≤ 0.017 after Bonferroni α-correction for multiple comparisons (n = 3 
comparisons; α = 0.05/3 = 0.017). 
 
For the “Fat heifers restriction study”, the mixed model was used, in which Hp or leptin was 
considered as a dependent variable; group (animals fed grass silage vs. animals fed silage: 
straw mixture) as a fixed factor, time as a repeated effect, in addition, the respective 
interaction was included into the model.  
 
For discriminating healthy from diseased animals by their Hp concentrations, the 
determination of the cut-off value was carried out using Youden’s index (Youden, 1950) a 
function of sensitivity and specificity (sensitivity + specificity - 1). The Receiver Operating 
Characteristics’ (ROC) curves were used to evaluate the quality of classification, in which the 
corresponding values for sensitivity and 1-specifity of various values were calculated and 
plotted against each other (Perkins and Schisterman, 2006).  
 
Correlations were calculated using Pearson’s correlation coefficient. The following general 
categories were used to describe the strength of correlation: 0 < r < 0.2 (very weak), 0.2 ≤ r < 
0.4 (weak), 0.4 ≤ r < 0.6 (moderate), 0.6 ≤ r < 0.8 (strong), and 0.8 ≤ r < 1.0 (very strong). All 
data are presented herein as means ± SEM. 
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3. Results 
 
3.1. Conjugated linoleic acid studies 
 
3.1.1. Haptoglobin 
 
3.1.1.1. Serum haptoglobin 
 
The timely changes of the concentrations of Hp during the entire experimental period (d –21 
until d 252 relative to parturition) for both heifers and cows in the CLA-252 DIM experiment 
are shown in Fig. 9.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 9. Haptoglobin serum concentrations (means ± SEM) in heifers and cows receiving 
conjugated linoleic acid (CLA, Lutrell Pure, BASF SE) at 50 or 100 g/day or a 
control fat supplement (CTR, Sila Fat, BASF SE) from d 1 until d 182 post 
partum in the CLA-252 DIM experiment. The statistical results included in the 
graph comprise the treatment and post-treatment period (d 1 - 252). [CTR: cows n = 
11, heifers n = 6; CLA-50: cows n = 11, heifers n = 5; CLA-100: cows n = 11, heifers 
n = 5)]. ns: not significant. 
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The results of all animals examined in the entire period showed that the concentrations of Hp 
were affected by parity (heifers vs. cows; P < 0.05) and parturition (before vs. after; P < 
0.001). The concentrations of Hp increased during the first week PP compared with the 
preceding values to 2.94 ± 0.98 mg/mL for heifers and 1.70 ± 0.67 mg/mL for cows. During 
the first week PP, the concentrations of Hp were higher in heifers than in cows. Hereafter, the 
concentrations of Hp were again decreased and irregularly fluctuated over the entire period 
for both parity groups. The statistical analysis over the PP period (d 1 - 252) for heifers and 
cows showed that only time was significant, whereas neither CLA treatment nor disease were 
significantly associated with the concentrations of Hp (Fig. 9). During the treatment period (d 
1 - 182 PP), there were no significant differences in the concentrations of Hp among the 
different treatments (CTR, CLA-50 and CLA-100) in both heifers and cows.   
 
In the CLA-PM-105 DIM experiment, the timely changes of the concentrations of Hp in 
heifers throughout the entire period (d –21 until d 105 relative to parturition) are presented in 
Fig. 10.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 10. Haptoglobin serum concentrations (means ± SEM) in heifers receiving 
conjugated linoleic acid (CLA, Lutrell Pure, BASF SE) at 100 g/day or a 
control fat supplement (CTR, Sila Fat, BASF SE) from d 1 until d 105 post 
partum in the CLA-PM-105 DIM experiment. The day of parturition is 
indicated by a vertical line. The statistical results included in the graph comprise 
the treatment period (d 1 - 105). [d –21 - 1: n = 25; d 7 - 42: n = 20 (10 each in 
CLA and CTR); d 105: n = 10 (5 each in CLA and CTR)]. ns: not significant. 
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The concentrations of Hp were affected by parturition (P < 0.001) with low values 3 weeks 
AP (0.35 ± 0.21 mg/mL), and elevated values during the first week PP (2.52 ± 0.61 mg/mL). 
Hereafter, the concentrations of Hp decreased again until d 105 PP. Further statistical analysis 
of the results revealed no significant differences in the concentrations of Hp during the first 
week PP between the heifers in this experiment and those in the CLA-252 DIM experiment. 
There were no differences in the concentrations of Hp between the CLA and CTR animals, as 
well as the concentrations of Hp were not affected by the health status of the animals (Fig. 
10).  
 
3.1.1.1.1. Relation of serum haptoglobin concentrations and body condition score, body 
weight, adipocyte size, fat mass, body fat content, concentrations of 
nonesterified fatty acids and β-hydroxybutyrate  
 
The correlations were calculated for different periods relative to parturition in both 
experiments, and presented herein as the coefficients of significant (P ≤ 0.05) correlations 
(summarized in appendix B; Tab. B1). Data for BCS, BW, adipocyte size, fat mass, NEFA 
and BHB were made available through the work of Akter et al. (2011), Pappritz et al. (2011) 
and von Soosten et al. (2011). 
When testing the potential relationships between the concentrations of Hp and BCS or BW, 
no correlations were observed in the CLA-252 DIM and the CLA-PM-105 DIM experiments 
during the entire experimental period or at certain dates. Adipocyte size, fat mass and body fat 
content recorded in the CLA-PM-105 DIM experiment were also not correlated with 
circulating Hp concentrations. 
For the cows in the CLA-252 DIM experiment, a very weak positive correlation was observed 
between the concentrations of Hp and NEFA in the following periods: d 21 AP - d 252 PP (r 
= 0.14, P ≤ 0.001), d 1 - 252 PP (r = 0.10, P ≤ 0.05), d 1 - 182 PP (r = 0.12, P ≤ 0.05), and a 
weak positive correlation on d 189 - 252 PP (r = 0.26, P ≤ 0.001). Concerning the BHB, a 
very weak positive correlation was recorded on d 21 AP - d 252 PP (r = 0.12, P ≤ 0.001), d 1 - 
252 PP (r = 0.11, P ≤ 0.05), and d 1 - 182 PP (r = 0.17, P ≤ 0.01). 
For the heifers in the CLA-252 DIM experiment, a weak positive correlation was recorded 
between the concentrations of Hp and NEFA on d 21 AP - d 252 PP (r = 0.38, P ≤ 0.001), a 
moderate correlation on d 1 - 252 PP (r = 0.43, P ≤ 0.001), and d 1 - 182 PP (r = 0.56, P ≤ 
0.001). In contrast, no relation was established between the concentrations of BHB and Hp. In 
the CLA-PM-105 DIM experiment, a moderate positive relation between the concentration of 
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Hp and NEFA was reported during the entire experimental period (d 21 AP - 105 PP: r = 0.54, 
P ≤ 0.001), the AP period (d 21 - 7: r = 0.46, P ≤ 0.001), and the PP period (d 1 - 105: r = 0.49, 
P ≤ 0.001), while a weak positive relation was reported between the concentrations of Hp and 
BHB (d 1 - 105: r = 0.23, P ≤ 0.01 and d 21 AP - 105 PP: r = 0.20, P ≤ 0.01). 
 
3.1.1.1.2. Haptoglobin as a measure of disease occurrence 
 
Disease events and incidence rates  
 
The disease events which were recorded for the animals in the CLA-252 DIM and the CLA-
PM-105 DIM experiments are presented in Tab. 1 and 2, respectively. In total, there were 59 
disease events in 41 animals (8 animals without any disease records) in the CLA-252 DIM 
experiment (Tab. 1), whereby more than one event at the same time and repeated events in 
one given animal had occurred. In the CLA-PM-105 DIM experiment, there were 32 disease 
events in 14 animals (11 animals without any records) (Tab. 2).  
 
Tab. 1. Disease events recorded for animals (heifers and cows) in the control and the 
conjugated linoleic acid treatment groups during the CLA-252 DIM 
experiment. 
 
 
Disease 
Cows                                 Heifers 
CTR 
(n = 11) 
CLA 
(n = 22) 
CTR 
(n = 6) 
CLA 
(n = 10) 
Mastitis       
Metritis 
Retained placenta  
Mouth disease* 
6 
3 
1 
2 
14 
8 
2 
5 
3 
4 
0 
1 
3 
4 
1 
2 
           *Mouth disease = whitlow or phlegmon. n: total number of animals. 
 
 
Tab. 2. Disease events recorded for heifers in the control and the conjugated linoleic acid 
treatment group during the CLA-PM-105 DIM experiment.  
 
 
Disease 
  d 1 (n = 5)            d 42  (n = 10)                      d 105 (n = 10) 
CTR               CTR             CLA              CTR               CLA 
Mastitis 1 0 2 3 3 
Metritis 0 2 4 1 3 
Retained placenta 1 1 2 1 1 
Diagnoses on slaughter day* 1 1 1 1 3 
*Abnormal findings during the slaughter process such as lung, liver, udder, uterus and rumen abscess. n: total number of animals. 
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The incidence rates ([number of cases/(number of animals x observation period (252 or 105 
d))] x 100) for the animals in the CLA studies (CLA-252 DIM and CLA-PM-105 DIM) are 
presented in Tab. 3, in which the rates were calculated regardless of the treatment. For 
mastitis, the incidence rates were 0.24% (cows; equivalent to 0.24 cases/100 cow/d) and 
0.15% (heifers; equivalent to 0.15 cases/100 cow/d) in the CLA-252 DIM experiment, and 
0.34% (heifers; equivalent to 0.34 cases/100 cow/d) in the CLA-PM-105 DIM experiment. 
The incidence rates for metritis were 0.13% (cows; equivalent to 0.13 cases/100 cow/d) and 
0.20% (heifers; 0.20 cases/100 cow/d) in the CLA-252 DIM experiment, and 0.38% (heifers; 
equivalent to 0.38 cases/100 cow/d) in the CLA-PM-105 DIM experiment. For retained 
placenta, the incidence rates were 0.04% (cows; equivalent to 0.04 cases/100 calvings) and 
0.03% (heifers; equivalent to 0.03 cases/100 calvings) in the CLA-252 DIM experiment, and 
0.23% (heifers; equivalent to 0.23 cases/100 calvings) in the CLA-PM-105 DIM experiment.  
 
Tab. 3. Disease incidence rates* (%) in the CLA-252 DIM and the CLA-PM-105 DIM 
experiments. 
 
 
Disease 
CLA-252 DIM CLA-PM-105 DIM 
Cows Heifers  Heifers 
Mastitis       
Metritis 
Retained placenta 
0.24 
0.13 
0.04 
0.15 
0.20 
0.03 
 0.45 
0.45 
0.29 
*
Disease incidence rate = [number of cases/(number of animals x observation period in days)] x 100. 
Observation period = 252 and 105 d in case of the CLA-252 DIM and the CLA-PM-105 DIM experiments, respectively. 
Example: In the CLA-252 DIM, 20 mastitis cases (6 CTR + 14 CLA) in cows. 
Incidence rate = [20 mastitis cases/(33 x 252)] x100 = 0.24. 
 
   
Determination of haptoglobin cut-off value 
 
An optimal cut-off value of 0.16 mg/mL for the serum concentrations of Hp in the CLA-252 
DIM experiment was determined using Youden index (Fig. 11) at maximal values of 59% 
sensitivity, 73% specificity and 0.32 for Youden index (Youden index (J) = max optimal cut- 
value (c) [sensitivity + specificity - 1]).  
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Fig. 11. ROC curve obtained using the concentrations of serum haptoglobin in the CLA-
252 DIM experiment to differentiate between animals diagnosed with diseases 
and those without. The vertical line identifies the Youden index (J, dotted line), and 
the corresponding optimal cut-value (c).  
 
 
Sample classification according to cut-off value of 0.16 mg/mL 
 
The sample classification according to the cut-off value of 0.16 mg/mL in both CLA 
experiments in the PP period is presented in Tab. 4. In the CLA-252 DIM experiment, ~ 60% 
of the serum samples of all animals in the CTR and CLA treatments had lower concentrations 
of Hp than 0.16 mg/mL, while ~
 
40% of the samples were higher than 0.16 mg/mL. In the 
CLA-PM-105 DIM experiment, 53% and 47% of the CTR and CLA samples had lower and 
higher concentrations of Hp than 0.16 mg/mL, respectively. 
 
Tab. 4. Sample classification according to a Hp-cut-off value of 0.16 mg/mL serum in the 
conjugated linoleic acid studies. 
 
Period1 Treatment n2 < Hp cut-off > n Pearson chi-square 
(P < 0.05) 
CLA-252 DIM 
d 1 - 252 
 
CTR 246 < 0.16 > 178 ns3 
CLA 193 < 0.16 > 119 
CLA-PM-105 DIM 
d 1 - 105 
CTR 35 < 0.16 > 31 ns 
CLA 35 < 0.16 > 30 
   1Period relative to parturition.2 number of samples below or above the cut-off value.3not significant. 
 
c 
J 
 
c = Optimal cut-point 
J = Youden index 
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Haptoglobin serum concentrations in healthy cows 
 
The concentrations of serum Hp from d 21 AP until d 21 PP for cows in the concentrate-
roughage ratio study are shown in Fig. 12.  
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 12. Haptoglobin serum concentrations (means ± SEM) in cows (n = 20) observed 
from d –21 until d 21 relative to parturition in the concentrate-roughage ratio 
study. The day of parturition is indicated by a vertical line. 
 
In the concentrate-roughage ratio study, where the cows fed LC (30% concentrate: 70% 
roughage) or HC (60% concentrate: 40% roughage) diets, the results indicated that the 
treatment had no significant effect on the concentrations of Hp, and therefore the data are 
presented herein as means from both treatments. The animals were apparently healthy; 
therefore, they were used to define the concentrations of Hp in healthy animals. The results 
showed that the concentrations of Hp peaked in the first week PP and then gradually declined 
until d 21 PP (Fig. 12). During the first week PP (as a mean from both d 1 and d 7), the cows 
used in this study had lower concentrations of Hp (P < 0.05) compared with cows (2.3-fold) 
and heifers (3.9-fold) used in the CLA-252 DIM experiment (Fig. 9), and heifers (2.4-fold) 
used in the CLA-PM-105 DIM experiment (Fig. 10). 
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3.1.1.2. Milk haptoglobin 
 
Haptoglobin in the CLA-PM-105 DIM experiment was detected in 54 out of 96 milk udder 
quarter samples (56%), whereas 42 samples (44%) were below the limit of detection of 0.07 
µg/mL.  
 
Classification of the animals according to udder health status 
 
The classification of the animals according to udder quarters into healthy (Hp < 2.2 µg/mL) 
and diseased (Hp ≥ 2.2 µg/mL) is presented in Tab. 5. The mean concentrations of milk Hp in 
the healthy quarters were 0.20 µg/mL (d 42 PP, CTR, n = 5), and 0.17 µg/mL (d 42 PP, CLA, 
n = 3). In contrast, the mean concentrations of milk Hp in the diseased quarters were 47.0 
µg/mL (d 1 PP, CTR, n = 4), 53.6 µg/mL (d 42 PP, CLA, n = 2), 2.9 µg/mL (d 105 PP, CTR, 
n = 4), and 6.9 µg/mL (d 105 PP, CLA, n = 5).  
 
Tab. 5. Classification of animals in the control and the conjugated linoleic acid 
treatment group according to a Hp-cut-off value of 2.2 µg/mL* milk in the 
CLA-PM-105 DIM experiment. 
 
 
Classification  
 
 
d 1 PP d 42 PP d 105 PP 
CTR CTR CLA CTR CLA 
(n = 4) (n = 5) (n = 5) (n = 5) (n = 5) 
Healthy quarters 
4/4 < 2.2 µg/mL 
 
 
 
 
- 
 
5 
 
3 
 
1 
 
- 
Diseased quarters 
1/4 ≥ 2.2 µg/mL 
2/4 ≥ 2.2 µg/mL 
3/4 ≥ 2.2 µg/mL 
4/4 ≥ 2.2 µg/mL 
 
 
 
 
 
1 
1 
- 
2 
 
- 
- 
- 
- 
 
- 
- 
- 
2 
 
2 
1 
- 
1 
 
2 
1 
2 
- 
*The cut-off value of 2.2 µg/mL was suggested by Hiss et al. (2007). n: number of animals. 
 
The Hp milk concentrations in the healthy and diseased quarters regardless of the treatment 
are presented in Fig. 13. The mean concentrations of Hp were 0.15 and 21.4 µg/mL in the 
healthy and in the diseased quarters, respectively. 
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Fig. 13. Haptoglobin milk concentrations in healthy and diseased udder quarters in the 
CLA-PM-105 DIM experiment. The plots show the medians (line within box), 25th 
and 75th percentiles (box), 10th and 90th percentiles (whiskers). The horizontal line 
indicated the cut-off value of 2.2 µg/mL. n: number of animals. The dot and star 
stand for the outliers and extreme values. 
 
The classification of the animals into healthy and diseased according to the SCC is 
summarized in Tab. 6.  
 
Tab. 6. Classification of animals in the control and the conjugated linoleic acid 
treatment group according to the somatic cell count in the CLA-PM-105 DIM 
experiment. 
 
 
Classification  
 
 
d 1 PP d 42 PP d 105 PP 
CTR CTR CLA CTR CLA 
(n = 2) (n = 2) (n = 3) (n = 5) (n = 5) 
Healthy quarters 
4/4 < 200 x 103 
 
 
 
 
- 
 
2 
 
- 
 
1 
 
- 
Diseased quarters 
1/4 > 200 x 103 
2/4 > 200 x 103 
3/4 > 200 x 103 
4/4 > 200 x 103 
 
 
 
 
 
- 
2 
- 
- 
 
- 
- 
- 
- 
 
1 
2 
- 
- 
 
2 
2 
- 
- 
 
1 
3 
- 
1 
n: number of animals. 
2.2 µg/mL 
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n = 9 
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n = 15 
150 
100 
0 
50 
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There were 26 out of 68 quarters (n = 17 heifers) with values > 200 x 103 cells/mL. The mean 
SCC values in the healthy quarters were 58 x 103 (d 42 PP, CTR) and 39.8 x 103/mL (d 105 
PP, CTR), whereupon in the diseased quarters the mean values were 353 x 103 (d 1 PP, CTR), 
1017 x 103 (d 42 PP, CLA), 340 x 103 (d 105 PP, CTR), and 463 x 103/mL (d 105 PP, CLA). 
 
3.1.1.3. Presence of haptoglobin in adipose tissue 
 
3.1.1.3.1. Qualitative description of haptoglobin by immunohistochemistry  
 
Haptoglobin immune reactive staining was detectable in all tested SC and VC AT depots and 
in lymph node sections which were used as positive controls. In AT, Hp immunoreactivity 
was observed in the adipocytes, whereas the cells of the stromal-vascular fraction were all 
negative. In the adipocytes, Hp positive staining was evident along the cytoplasmic rim 
surrounding the large fat droplets (Fig. 14A), cytoplasmic rim edges (Fig. 14B) or as spot dots 
(Fig. 14C). Bovine lymph node tissue showed a punctuate, specific staining for Hp (Fig. 
14D). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
  
                                      
Fig. 14. Representative images showing haptoglobin positive staining in adipose tissue 
sections and in lymph node tissue used as positive control. (A) Along the 
cytoplasmic rim (retroperitoneal tissue); (B) Cytoplasmic rim edges (subcutaneous 
withers tissue); (C) Spot dots (subcutaneous withers tissue); (D) Positive control 
(bovine lymph node tissue). Original magnification: 200x. Bars represent 50 µm. 
Arrows indicated Hp positive staining (red color).  
A  B  
D   C  
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3.1.1.3.2. Detection of haptoglobin by Western immunoblotting  
 
The primary antibody which was used in the immunohistochemical detection (as mentioned in 
the materials and methods section) was validated for it’s reactivity in the liver and SC tailhead 
fat (Fig. 15A). The primary antibody reacted with bands of molecular weights from 20 to 
34 kDa for liver and from 26 to 55 kDa for SC tailhead fat. The Western immunoblotting was 
used to detect any differences in the molecular weights between liver and serum samples as 
compared to SC tailhead fat (Fig. 15B). The results indicated that liver and serum bands were 
obtained on 34, 26 and 20 kDa molecular weights, while SC tailhead fat bands was obtained 
on 26 and 55 kDa molecular weights.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 15. Western immunoblot analysis of haptoglobin in bovine liver, subcutaneous 
tailhead fat and serum. (A) Test of antibody cross-reactivity in liver and 
subcutaneous tailhead fat. Lanes from left to right: (1) molecular marker in kDa; (2, 
3, 8) - primary antibody and + secondary antibody; (4, 5, 9) + primary antibody and 
- secondary antibody; (6, 7, 10) + primary antibody and + secondary antibody. (B) 
Comparisons of liver, subcutaneous tailhead fat and serum. 
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3.1.1.3.3. Haptoglobin in subcutaneous and visceral adipose tissue 
 
The results of histological localization of Hp indicated that VC fat had always higher portions 
of Hp positive cells than SC fat in both CLA and CTR treatments (Fig. 16).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 16. Percentage (± SEM) of haptoglobin positive adipocyte cells in three visceral 
(VC) (upper panel) and three subcutaneous (SC) depots (lower panel) in heifers 
receiving conjugated linoleic acid (CLA, Lutrell Pure, BASF SE) or a control 
fat supplement (CTR, Sila Fat, BASF SE) at 100 g/day from d 1 until d 105 
post partum in the CLA-PM-105 DIM experiment. Disease as random effect was 
not significant. Significant timely differences within the CTR group are shown by 
different letters; treatment effects are shown by brackets and stars. ns: not 
significant. 
 
Comparing the different times of lactation, the VC depots underwent significant but 
inconsistent changes. In the CTR treatment, the percentage of Hp positive cells in the 
retroperitoneal tissue was significantly lower in d 1 PP compared to d 42 and 105 PP, in 
which the portion of percentage of positive cells increased 1.8-fold from d 1 to 105 PP.  In 
contrast, mesenterial tissue from d 105 had only 25% of the values from d 1. For omental 
tissue, the portion of positive cells peaked on d 42, reaching 2-fold higher values than on d 1 
and 105 PP. There were no significant differences in Hp positive cells in SC depots from 
sternum and tailhead with time, whereas the SC from withers had similar changes as observed 
in omental fat. Conjugated linoleic acid reduced significantly the percentage of Hp positive 
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cells in omental tissue by 4.3-fold (d 42) and increased significantly in mesenterial tissue in d 
105 PP. No significant differences were found in the percentage of Hp positive cells between 
CTR and CLA treatments in the other tissues (Fig. 16). 
 
3.1.2. Leptin 
 
The concentrations of leptin for all animals (heifers and cows) from d –21 until d 252 relative 
to parturition in the CLA-252 DIM experiment are demonstrated in Fig. 17. There were no 
significant differences in the concentrations of leptin in terms of parity (heifers vs. cows), 
whereas the concentrations of leptin were affected by parturition (before vs. after parturition; 
P < 0.001). The concentrations of leptin were high in the AP period with a mean of 5.93 ± 
0.53 ng/mL, and then the concentrations decreased PP below the pregnancy concentrations to 
4.65 ± 0.43 ng/mL.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 17. Leptin serum concentrations (means ± SEM) in animals (n = 49) receiving 
conjugated linoleic acid (CLA, Lutrell Pure, BASF SE) at 50 or 100 g/day or a 
control fat supplement (CTR, Sila Fat, BASF SE) from d 1 until d 182 post 
partum in the CLA-252 DIM experiment. The statistical results included in the 
graph comprise the treatment and post-treatment period (d 1 - 252). [(CTR: n = 17; 
CLA-50: n = 16; CLA-100: n = 16)]. ns: not significant. 
 
The statistical analysis from d 1 until d 252 PP for all animals confirmed no significant effects 
of CLA treatment, time and their interactions on the concentrations of leptin. During the 
treatment period (d 1 - 182 PP), the concentrations of leptin remained unaffected by CLA 
supplementation.  
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In the CLA-PM-105 DIM experiment, the changes in the concentrations of leptin from d –21 
until d 105 relative to parturition are shown in Fig. 18. The concentrations of leptin were 
reduced (P < 0.05) PP (4.88 ± 0.46 ng/mL) as compared to AP (5.49 ± 0.54 ng/mL). The 
concentrations of leptin were not affected by CLA treatment (d 1 - 105 PP; Fig. 18).  
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 18. Leptin serum concentrations (means ± SEM) in heifers receiving conjugated 
linoleic acid (CLA, Lutrell Pure, BASF SE) at 100 g/day or a control fat 
supplement (CTR, Sila Fat, BASF SE) from d 1 until d 105 post partum in the 
CLA-PM-105 DIM experiment. The day of parturition and CLA supplementation 
is indicated by a vertical line. The statistical results included in the graph comprise 
the treatment period (d 1 - 105). [(d –21 - 1: n = 25; d 7 - 42: n = 20 (10 each in 
CLA and CTR); d 105: n = 10 (5 each in CLA and CTR)]. ns: not significant. 
 
 
Relation of serum leptin concentrations and body condition score, body weight, 
adipocyte size, fat mass, body fat content, concentrations of nonesterified fatty acids and 
β-hydroxybutyrate  
 
The correlations were examined in different periods relative to parturition in both 
experiments, and presented herein as the coefficients of significant (P ≤ 0.05) correlations 
(summarized in appendix B; Tab. B2 and B3). Data for BCS, BW, adipocyte size, fat mass, 
NEFA and BHB were made available through the work of Akter et al. (2011), Pappritz et al. 
(2011) and von Soosten et al. (2011). 
 
In the CLA-252 DIM experiment, a very weak positive correlation between the 
concentrations of leptin and BCS was observed from d 21 AP until d 252 PP (r = 0.19, P ≤ 
0.001), and d 189 - 252 PP (r = 0.18, P ≤ 0.01). In the CLA-PM-105 DIM experiment, a weak 
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positive relation between the concentrations of leptin and BCS was recorded in the AP period 
(d 21 - 7: r = 0.27, P ≤ 0.05) and in the PP period (d 1 - 105: r = 0.34, P ≤ 0.001). Concerning 
BW, a moderate positive relation (d 1 - 105: r = 0.46, P ≤ 0.001) was found only in the CLA-
PM-105 DIM experiment.  
 
In the CLA-PM-105 DIM experiment, there was a very strong positive correlation between 
the concentrations of leptin and adipocyte size on d 1 PP (mesenterial tissue: r = 0.98, P ≤ 
0.01), and a strong positive relation on d 105 PP (retroperitoneal tissue: r = 0.75, P ≤ 0.05; SC 
withers: r = 0.78, P ≤ 0.01, and SC sternum: r = 0.71, P ≤ 0.05). A very strong positive 
correlation was recorded between leptin and fat mass on d 42 PP in omental (r = 0.90, P ≤ 
0.001), retroperitoneal (r = 0.81, P ≤ 0.01), and SC (r = 0.83, P ≤ 0.01) as well as a strong 
relation in mesenterial (r = 0.71, P ≤ 0.05). A very strong positive correlation was recorded 
between the concentrations of leptin and body fat content on d 42 PP in omental (r = 0.86, P ≤ 
0.001), retroperitoneal (r = 0.83, P ≤ 0.01), and SC (r = 0.80, P ≤ 0.01) as well as a strong 
relation in mesenterial fat (r = 0.72, P ≤ 0.05). A very strong positive correlation was found 
between the concentrations of leptin and the total fat mass (r = 0.88, P ≤ 0.001) and total body 
fat content (r = 0.91, P ≤ 0.001) on d 42 PP. 
 
In the CLA-252 DIM experiment, a very weak inverse correlation was observed between the 
concentrations of leptin and NEFA in the following periods: d 21 AP - d 252 PP (r = -0.15, P 
≤ 0.001), d 1 - 252 PP (r = -0.11, P ≤ 0.01) and d 1 - 182 PP (r = -0.1, P ≤ 0.05). In contrast, no 
correlation was reported between BHB and the concentrations of leptin in the CLA-252 DIM. 
In the CLA-PM-105 DIM experiment, no correlation was found between the concentrations 
of leptin and NEFA, while a weak positive relation was recorded with BHB (d 1 - 105: r = 
0.34, P ≤ 0.001). 
 
3.2. Effect of fat mobilization on the concentrations of haptoglobin and leptin in the fat 
heifers restriction study 
 
The changes in the concentrations of Hp and leptin in the fat heifers restriction study are 
shown in Fig. 19A and B, respectively. There were no significant differences in the 
concentrations of Hp and leptin between animals fed either grass silage or hay/silage-straw 
mixture. In general, the concentrations of Hp and leptin varied slightly from week to week 
and did not show consistent changes across the investigated period. 
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Fig. 19. Haptoglobin (A) and leptin (B) serum concentrations (means ± SEM) in non-
lactating heifers receiving hay/silage-straw mixture (n = 6) or grass silage (n = 
6) for 4 weeks and only grass silage (n = 12) for 3 weeks thereafter in the fat 
heifers restriction study. The vertical lines indicate the differential feeding period. 
The statistical results included in the graph comprise the differential feeding period. 
ns: not significant. 
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4. Discussion 
 
4.1. Characterization of haptoglobin and leptin concentrations throughout lactation or 
during early lactation in the conjugated linoleic acid studies  
 
The CLA studies consisted of two independent experiments; the CLA-252 DIM comprising 
heifers (n = 16) and cows (n = 33) observed from d 21 AP until d 252 PP, and the CLA-PM-
105 DIM conducted on heifers (n = 25) only for a period from d 21 AP until d 105 PP. 
 
Serum haptoglobin concentrations  
 
The physiological changes observed during the CLA-252 DIM experiment were related to 
parity (heifers vs. cows) and parturition (before vs. after). During the first week after 
parturition, the concentrations of Hp were 1.7-fold higher in heifers than in cows. These 
results are in agreement with those obtained by Humblet et al. (2006) (study period: 8 weeks 
AP until 16 weeks PP), who demonstrated that heifers had 2.2-fold higher concentrations of 
Hp than cows in the first week following parturition. Moreover, Crawford et al. (2005) 
investigated heifers and cows from 3 weeks AP until 6 weeks PP and reported Hp 
concentrations being 1.3-fold higher in heifers than in cows during the first week after 
parturition. Furthermore, higher concentrations of Hp (1.9-fold) and ceruloplasmin (1.2-fold) 
have been reported during the first 27 d PP in heifers than in cows (Cullens, 2005). In 
contrast, Crawford et al. (2005) stated that there was no difference in the concentrations of Hp 
between cows and heifers in week 6 PP. The reason for the mostly higher concentrations of 
Hp recorded in heifers than in cows in the first week PP is not clear. It might be that 
parturition is more stressful for heifers than for cows. It could be concluded that our finding 
suggests a more intense physiological response to first calving than to later ones as suggested 
by Humblet et al. (2006).  
 
In the current study, the concentrations of Hp peaked around calving and decreased 
afterwards in both the CLA-252 DIM and the CLA-PM-105-DIM experiments. This finding 
is in agreement with the studies of Uchida et al. (1993), Hachenberg et al. (2007), Tóthová et 
al. (2008) and Kováč et al. (2009). This increase is probably related to the hormonal changes 
and the tissue lesions occurring during birth (Young et al., 1995; Hachenberg et al., 2007). 
However, the increase in energy requirements during the transition period results in NEB, and 
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therefore energy has to be mobilized from AT. This process results in increased circulating 
concentrations of NEFA and formation of ketone bodies (Herdt, 2000). Thus, the transition 
period in dairy cows presents a risk for metabolic disturbances such as fatty liver and ketosis. 
The APR is associated with numerous changes in lipid metabolism such as accelerated 
lipolysis and increased NEFA in plasma (Hardardóttir et al., 1994). Hiss et al. (2009) and 
Kováč et al. (2009) suggested that in cows with higher concentrations of NEFA, higher 
concentrations of Hp might be found. However, Uchida et al. (1993) showed that 
experimentally induced fatty liver was associated with increasing concentrations of Hp; 
therefore a part of this increase in the first week PP could be caused by NEB and metabolic 
stress (Crawford et al., 2005). In the current study, the relation between the concentrations of 
serum Hp and each of NEFA and BHB (Pappritz et al., 2011; von Soosten et al., 2011) was 
assessed. In the CLA-252 DIM (cows and heifers) and CLA-PM-105 DIM (heifers) 
experiments, a positive relation was recorded between the concentrations of Hp and each of 
NEFA and BHB. This finding is in accordance with Kováč et al. (2009) who also found a 
positive correlation between Hp and some variables of energy metabolism such as NEFA and 
BHB. In both experiments (CLA-252 DIM and CLA-PM-105 DIM), the concentrations of Hp 
showed a stronger positive correlation with NEFA in heifers than in cows; therefore it might 
be that heifers are more stressed by lipolysis than cows. 
 
The current study indicated that the time course of the concentrations of Hp after the first 
week of lactation did not show marked changes, which is in line with Humblet et al. (2006) 
(study period: 8 weeks AP until 16 weeks PP) who reported no significant effects of time on 
the concentrations of Hp after the first week PP.  
 
Serum leptin concentrations 
 
The present study demonstrated that physiological alterations in the concentrations of serum 
leptin in the CLA-252 DIM experiment were limited to parturition (before vs. after), whereas 
no parity (heifers vs. cows) differences could be found. Conversely, other researchers reported 
that the concentrations of leptin are affected by parity, whereby circulating leptin is 
significantly higher in heifers than in cows before calving (Wathes et al., 2007), and the 
peripartal decrease was steeper in heifers than in cows around calving (Meikle et al., 2004; 
Wathes et al., 2007). Heifers generally calve for the first time at about 24 months of age 
(Hoffman and Funk, 1992), and they are not physically mature at this stage (Coffey et al., 
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2006). Thus, heifers approaching their first calving are in a differing metabolic state to that 
experienced by cows as they require nutrients for their own continued growth in addition to 
that of their developing calf (Wathes et al., 2007). However, the steeper decrease in the 
concentrations of leptin in heifers might be explained by that heifers showed a 
metabolic/endocrine profile less balanced (e.g. higher NEFA and BHB, lower insulin-like 
growth factor-I (IGF-I) and thyroid hormones) than cows (Meikle et al., 2004). This reflects 
that heifers are recovering from the NEB period with more difficulty. Ehrhardt et al. (2000) 
estimated that BCS in late pregnant cows explained 37% of the variation in plasma leptin. In 
addition, Wathes et al. (2007) reported that the higher circulating leptin in heifers before 
calving might relate to the tendency towards a slightly higher BCS than cows. Both heifers 
and cows used in the present study (CLA-252 DIM experiment) had a BCS of 3.5 before 
calving; therefore, this might explain why parity did not significantly affect the concentrations 
of leptin. 
 
In the present study, the concentrations of leptin were high during late pregnancy and 
declined towards parturition, and then remained low in both CLA-252 DIM and CLA-PM-
105-DIM experiments. This finding is in agreement with several previous studies (Block et 
al., 2001; Liefers et al., 2005; Hachenberg et al., 2007; Wathes et al., 2007). The high 
concentrations of leptin during pregnancy are due to an increase in body fat reserves and a 
concomitant increase in leptin mRNA expression in AT (Ehrhardt et al., 2001). The decline in 
the concentrations of plasma leptin towards parturition with the onset of NEB is probably 
caused by the inhibition of leptin expression by AT (Block et al., 2001), and increased 
mobilization of AT (Liefers et al., 2005). Recently published studies, using the same animals 
that were used in the current study, indicated that positive EB was achieved after d 49 
(Pappritz et al., 2011) and d 14 PP (von Soosten et al., 2011) in the CLA-252 DIM and CLA-
PM-105 DIM experiments, respectively. In addition, the highest mobilization of AT, 
according to the concentrations of NEFA, occurred from d 7 AP until d 21 PP in both 
experiments (Pappritz et al., 2011; von Soosten et al., 2011). The onset of NEB around 
parturition is associated with decreased plasma insulin and increased plasma GH (Block et al., 
2001), suggesting that both hormones could mediate a portion of the effect of EB on plasma 
leptin and attribute to the reduction of leptin concentrations towards parturition.  
 
In humans and rodents, leptin is synthesized in proportion to the overall degree of adiposity 
(Friedman and Halaas, 1998). Similar relationships have been observed between leptin and 
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body fatness in ruminants (Blache et al., 2000; Thomas et al., 2001; Altmann et al., 2006), 
BCS (Ehrhardt et al., 2000; Delavaud et al., 2002) and adipocyte size (Delavaud et al., 2002). 
In the current study, the relationship between the concentrations of serum leptin and each of 
BCS, BW (Pappritz et al., 2011; von Soosten et al., 2011), fat mass and body fat content (von 
Soosten et al., 2011), and adipocyte size (Akter et al., 2011) on different days relative to 
parturition was tested in both experiments. The concentrations of leptin had a stronger relation 
with depots fat mass, body fat content, and adipocyte size than BCS. These observations 
confirm those of Delavaud et al. (2002) who reported that plasma leptin is more strongly 
related to adipose cell size (r = 0.91) than to BCS (r = 0.54). This finding suggests that the 
increase in leptin that is observed when adiposity increases is strongly related to hypertrophy 
of adipose cells as reported by Delavaud et al. (2002).  
 
In addition, the relationship between the concentrations of serum leptin and both of NEFA 
and BHB was tested in both experiments of the current study. It was found that the 
concentrations of leptin were negatively correlated with NEFA, and positively with BHB. The 
present results are in agreement with those of Block et al. (2001) and Accorsi et al. (2005) 
who reported that the concentrations of plasma leptin were negatively related to the 
concentrations of NEFA. Block et al. (2001) reported that the significant correlations between 
the plasma concentrations of leptin, insulin, GH, glucose and NEFA could represent co-
regulation by EB, and perhaps a role for these factors in mediating the effect of EB on leptin 
synthesis. At the beginning of lactation, GH concentrations increased, while a reduction 
occurred in leptin and insulin. This endocrine condition, such as the significant increase in 
NEFA plasma concentrations, is indicative of a marked lipid mobilization. In the more 
advanced stages of lactation, when both energy and protein balances become positive, leptin 
plasma concentrations increased, whereas NEFA concentrations declined (Accorsi et al., 
2005). 
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4.2. Effect of supplementation with conjugated linoleic acids on serum haptoglobin and 
leptin  
 
Efficacy of the treatments with conjugated linoleic acids  
 
The efficacy of the CLA supplementation in terms of milk fat reduction has been reported in 
both experiments using the same animals used in the present study (Pappritz et al., 2011; von 
Soosten et al., 2011). In the CLA-252 DIM experiment, Pappritz et al. (2011) reported that the 
CLA supplementation (d 56 until d 182 PP) resulted in a reduction of milk fat content by 7 
and 12% in the CLA-50 and in the CLA-100 group, respectively. In the CLA-PM-105 DIM 
experiment, the CLA supplementation decreased milk fat content by 14.1% (d 1 until d 42 
PP) and 25.4% (d 42 until d 105 PP) (von Soosten et al., 2011). In the CLA-252 DIM 
experiment, BW, BCS, plasma concentrations of glucose, BHB and NEFA did not differ 
among treatments over the CLA supplementation period although there was a trend for lower 
plasma NEFA concentrations in the CLA-100 animals from d 21 until d 182 PP (Pappritz et 
al., 2011). In the CLA-PM-105 DIM experiment, BW, BCS, NEFA, BHB and glucose were 
not changed by CLA supplementation in any period of experiment (von Soosten et al., 2011). 
Conjugated linoleic acids supplementation did not affect the weights of liver, VC (omental, 
mesenteric), or SC adipose depots with the exception of retroperitoneal fat, in which a trend 
to a lower weight of animals slaughtered on d 42 PP and d 105 PP was observed (von Soosten 
et al., 2011). Akter et al. (2011) reported that dietary CLA supplementation decreased 
adipocyte sizes of different SC and VC depots to different extents in dairy cows during the 
first 105 d PP. Moreover, the extent of CLA-induced decrease of adipocyte sizes is 
consistently higher at d 105 PP than at d 42 PP for both SC and VC depots. They concluded 
that CLA-induced decrease in adipocyte size indicates that CLA does affect body fat in dairy 
cows. 
 
Effect of supplementation with conjugated linoleic acids on serum haptoglobin 
 
The functioning of the immune system, like most systems in the body, is dependent on 
adequate nutrition. Moreover, nutrition signals can affect gene and protein expression which 
modulate the inflammation markers depending on the net changes in gene expression and 
resulting in both positive and negative effects (do Nascimento et al., 2009). Fatty acids are 
important modulators of the immune system (Calder, 2008; Serhan et al., 2008). In a number 
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of different animals, CLA has been suggested to have anti-inflammatory and/or immune-
ameliorating effects (Yu et al., 2002). The c-9, t-11 and t-10, c-12 isomers of CLA induce a 
number of physiological effects, some by the independent actions of a single isomer, others 
by (synergistic) interactions involving both isomers (Pariza et al., 2001). Moreover, the c-9, t-
11 and t-10, c-12 CLA isomers have been reported for possessing anti-inflammatory effects 
(Huebner et al., 2010). In contrast, the t-10, c-12 CLA isomer has also been reported to induce 
inflammation (Poirier et al., 2006). However, to the best of our knowledge this is the first 
report on the effect of CLA supplementation on Hp in ruminants. The present investigation 
demonstrated that long-term feeding of dairy cows with CLA containing 12% of the t-10, c-
12 and c-9, t-11 CLA isomers in equal proportions, had no effect on the concentrations of 
serum Hp in both experiments. However, one study in rats indicated a reduction in the 
concentrations of serum Hp fed 1.5% (1.5 g/100 g of total ration) CLA isomers (t-10, c-12; c-
9, t-11; c-11, t-13 and t-8, c-10) for 8 weeks (Noto et al., 2007). Contradictory results of other 
inflammation markers are reported in literature: supplementation with 3.4 g/d CLA (purified 
t-10, c-12) in men with metabolic syndrome for 12 weeks significantly increased CRP (2.2-
fold), but no significant increase was found for TNF-α and IL-6 (Risérus et al., 2002). In non 
obese humans, 3.2 g/d CLA (equal amounts of c-9, t-11 and t-10, c-12 isomers) for 12 weeks 
increased CRP, but CLA supplementation did not have any significant effect on plasma 
concentrations of TNF-α (Smedman et al., 2005). In contrast, Moloney et al. (2004) found no 
effect of 3 g/d CLA (50:50 blend of c-9, t-11 and t-10, c-12) supplemented for 8 weeks, on 
CRP or IL-6 in human subjects with type 2 diabetes. 
 
Effect of supplementation with conjugated linoleic acids on serum leptin 
 
Leptin is a protein secreted from adipocytes that has been implicated in the regulation of food 
intake, energy expenditure and whole-body EB. However, because CLA is reported to reduce 
body fat content in humans (Thom et al., 2001), rats (Yamasaki et al., 2000), mice (DeLany et 
al., 1999), and pigs (Ostrowska et al., 1999) as well as to induce reductions in adipocyte size 
in rats (Poulos et al., 2001), mice (Tsuboyama-Kasaoka et al., 2000) and dairy cows (Akter et 
al., 2011), CLA supplementation has been linked to a reduction of circulating leptin 
concentrations in rats (Rahman et al., 2001), mice (Parra et al., 2010), and humans (Medina et 
al., 2000). In addition, CLA may act directly on leptin production because it could reduce 
leptin without affecting the BW and body fat content as reported in humans (Medina et al., 
2000) and rats (Yamasaki et al., 2003). The t-10, c-12 CLA isomer has been suggested to 
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decrease and the c-9, t-11 CLA isomer to increase leptin secretion and gene expression 
(Rodríguez et al., 2002; Ahn et al., 2006; Gudbrandsen et al., 2009). However, the present 
results showed that long-term feeding of dairy cows with CLA containing 12% of the t-10, c-
12 and c-9, t-11 CLA isomers in equal parts had no significant effect on the concentrations of 
serum leptin in both experiments. This finding is in line with a relatively short study (5 days) 
on dairy cows in mid to late lactation receiving 10 g/d abomasal infusions of either c-9, t-11 
or t-10, c-12 CLA isomer and reporting no effect of CLA treatment on the concentrations of 
plasma leptin (Baumgard et al., 2002). In addition, Gillis et al. (2004b) reported that feeding 
beef heifers 2% (of total ration on DM basis) rumen-protected CLA salts (a mixture of Ca-
salts of palm oil FA with 31% CLA (27.2% c-9, t-11; 32.8% t-10, c-12; 10.6% t-8, c-10; 
18.95% c-11, t-13 and 10.5% various t, t CLA isomers)) on the last 32 or 60 days before 
slaughter had no effect on the concentrations of serum leptin.  
 
Long-term CLA supplementation after calving left the concentrations of serum Hp and leptin 
unaffected. In this study, it is difficult to make definite conclusions on the long-term CLA 
supplementation effect on the concentrations of Hp and leptin. The reasons for the lack of a 
CLA effect are unknown, but it is likely that dose, duration and the isomeric composition of 
CLA separately affect the ability of CLA to influence the concentrations of Hp and leptin in 
dairy cows. In addition, the individual dietary intake from the c-9, t-11 and t-10, c-12 CLA 
isomers was lower than planned in the CLA-252 DIM and CLA-PM-105 DIM experiments. 
The aim of the CLA-252 DIM experiment was to achieve an individual dietary intake of 5 and 
10 g/d of t-10, c-12 and c-9, t-11 CLA isomers in CLA-50 and CLA-100 groups, respectively. 
However, Pappritz et al. (2011) reported that the calculated intakes, based on the analyzed 
concentrations given in feed-concentrates, were 20% lower than expected (4 and 8 g/d of t-10, 
c-12 and c-9, t-11 CLA isomers in CLA-50 and CLA-100, respectively). In the CLA-PM-105 
DIM experiment, the aim was to achieve an individual dietary intake of 10 g/d of t-10, c-12 
and c-9, t-11 CLA isomers in CLA-100, but von Soosten et al. (2011) reported that the 
animals of the CLA group consumed only 6 g/d of the t-10, c-12 and c-9, t-11 CLA isomers 
(40% lower than planned). 
The unsaturated FA, which are preferentially saturated by ruminal microorganisms, must 
either be protected from ruminal biohydrogenation or be presented in amounts high enough to 
result in sufficient escape to the intestinal tract for absorption (Gillis et al., 2004a). In 
ruminant animals, FA composition of AT depots is dependent on: 1) supply of dietary FA to 
depots as influenced by the extent of ruminal biohydrogenation, as well as intestinal 
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absorption rates; 2) de novo synthesis of FA from precursors supplied to AT; and 3) rate of 
desaturation by the AT enzyme, ∆9-desaturase (Enser et al., 1999). However, in the current 
study, another reason for the lack of a CLA effect could be that the uptake of the c-9, t-11 and 
t-10, c-12 CLA isomers by different tissues was insufficient to elicit metabolic effects. The 
effect of CLA supplementation on the FA distribution in different tissues has been reported in 
both experiments using the same animals as in the present study (Kramer et al., 2010, 2011). 
In the CLA-252 DIM experiment, Kramer et al. (2010) evaluated the effect of CLA 
supplementation on FA distribution of liver and SC AT (biopsy samples collected on d 21 AP, 
1, 21, 70 and 105 PP) and reported that the FA distribution and FA ratios showed no 
significant differences between the CTR and the supplemented groups (CLA-50 and CLA-
100). Thus, an effect of the CLA supplementation on the FA synthesis and ∆9 desaturation in 
liver and AT could not be observed (Kramer et al., 2010). In the CLA-PM-105 DIM 
experiment, the FA distribution of liver tissue showed no significant changes between CTR 
and CLA supplement on d 105 PP. In contrast, retroperitoneal fat showed significant changes 
of c-9, t-11 (0.18% (CTR) to 0.24% (CLA) of FA methyl esters), and t-10, c-12 (0.00% 
(CTR) to 0.01% (CLA) of FA methyl esters) CLA isomers on d 105 PP (Kramer et al., 2011). 
Data on FA distribution and FA ratios for other fat tissues are not available yet. 
 
4.3. Presence of haptoglobin in adipose tissue 
 
The IHC method used in this study confirmed that Hp is present in all tested bovine AT, 
which is consistent with results obtained in mice (Friedrichs et al., 1995; Chiellini et al., 2002; 
do Nascimento et al., 2004), and in humans (Fain et al., 2004). Based on our results the 
presence of Hp is likely attributable to the adipocytes which is in agreement with Friedrichs et 
al. (1995), Chiellini et al. (2002), and do Nascimento et al. (2004). In contrast, Fain et al. 
(2004) reported that more Hp is made by the nonfat cells of human AT explants than is made 
by adipocytes. In the heifers investigated herein, the histological localization of Hp showed 
that VC fat had higher portions of Hp positive cells than SC fat. This finding is consistent 
with Fain et al. (2004) who reported that explants of human VC depots released more Hp than 
those of SC depots, and this might be due to the metabolic differences between the depots as 
mentioned previously in section 1.2. 
 
The Western immunoblotting method further confirmed the presence of Hp in AT. This 
method demonstrated differences in the obtained molecular weights of Hp in SC tailhead fat 
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(26 and 55 kDa) as compared to the liver or serum (34, 26 and 20 kDa). This finding is in line 
with Dilda et al. (2011) who reported several isoforms of Hp in bovine gastric tissues (16 and 
45 kDa in rumen and abomasum) that differed from those expressed in the liver (14 and 39 
kDa). Furthermore, Cooray et al. (2007) mentioned that the bovine granulocyte Hp consists of 
α (20 kDa) and β (40 kDa) chains each containing four and five isoforms, respectively. The 
reason for these differences is not clear, but differences in the glycosylation patterns of this 
protein have the potential to change its molecular weight (Wilson et al., 2002). Furthermore, it 
is also possible that specific glycosylation patterns, for proteins in general, are expressed in a 
tissue-specific and developmentally regulated manner (Ervasti et al., 1997). However, further 
investigations are required to ensure the protein identity. Taken together, these findings (by 
IHC and Western immunoblotting methods) provide an indication that Hp could be classified 
as an adipokine in ruminants as reported in humans (Chiellini et al., 2004; Fain et al., 2004). 
Within AT, Hp can play a role as a monocyte chemoattractant factor (Maffei et al., 2009), and 
as an antioxidant or angiogenesis agent (do Nascimento et al., 2009). However, further studies 
are required to give insight on Hp functions in bovine AT.  
 
It was suggested that Hp is also associated with obesity because its serum concentrations are 
increased in obese humans (Chiellini et al., 2004), and this is consistent with the concept that 
obesity is a state of chronic mild inflammation (do Nascimento et al., 2004). Unlike human 
studies, less is known about the relation between Hp and obesity in ruminants. In the current 
study, no relationship between serum Hp and each of BCS, BW and body fat content was 
established in both CLA experiments (not obese or over conditioned animals). In the over 
conditioned non-lactating heifers (fat heifers restriction study) there was a moderate negative 
correlation, which was completely surprising, between the concentrations of serum Hp and 
BW (r = -0.51, P = 0.002). Conversely, Chiellini et al. (2004) reported a strong positive 
relationship between circulating Hp and body fat in humans. The question as to whether the 
concentrations of Hp in serum might change in lactating cows if fat mass exceeds a certain 
level is unresolved yet. In addition, it is probable that Hp as an adiposity marker is irrelevant 
for ruminants.  
 
4.4. Haptoglobin as an inflammation marker  
 
Haptoglobin being one of the major APPs in cattle, is synthesized in response to infection and 
inflammation, with low constitutive serum concentrations under normal conditions ranging 
from 0.05 to 0.10 mg/mL (Svensson et al., 2007), exhibits a high relative increase up to 50 - 
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100-fold (Godson et al., 1996) and 1000-fold (Eckersall et al., 2006) in response to different 
inflammatory stimuli. Hirvonen et al. (1999) reported that the concentrations of Hp were high 
in cows with mastitis, metritis, and other inflammatory processes.  
 
In the CLA studies, the clinical examination of the animals revealed disorders of their general 
health conditions such as mastitis, metritis and retained placenta. These diseases are 
considered as being of economic importance for dairy production (Kelton et al., 1998), and 
can dramatically affect the profitability of dairy herds (Kossaibati and Esslemont, 1997). 
Disease frequency is usually reported either as incidence (the occurrence rate of disease cases 
per unit of time) or prevalence (the proportion of animals that are diseased at any single point 
in time) (Kelton et al., 1998). For mastitis, the incidence rates in the CLA-252 DIM 
experiment were 0.24 and 0.15 cases/100 cow/d for cows and heifers, respectively, and the 
incidence rate in the CLA-PM-105 DIM experiment was 0.45 cases/100 cow/d. The incidence 
rate of heifers in the CLA-252 DIM experiment is consistent with that of Plym-Forshell et al. 
(1995) who reported 56 cases/100 cow/year (equivalent to 0.153 cases/100 cow/d) in 
Denmark, and Erskine et al. (1988) who reported an incidence rate of 4.23 cases/100 
cow/month (equivalent to 0.141 cases/100 cow/d) in the USA. The incidence rates in our 
study in both experiments were higher than those reported by Gianneechini et al. (2002) (1.2 
cases/100 cow/month) in Uruguay, and Plym-Forshell et al. (1995) (21 cases/100 cow/year) in 
Sweden, which as daily incidence can be estimated as 0.04 and 0.06 cases/100 cow/d, 
respectively. The incidence rates for metritis in the CLA-252 DIM experiment were 0.13 and 
0.20 cases/100 cow/d for cows and heifers, respectively, whereas the incidence rate in the 
CLA-PM-105 DIM experiment was 0.45 cases/100 cow/d. These rates are considered low 
compared to Emanuelson et al. (1993) who reported 2.2 cases/100 cow/d in Sweden. For 
retained placenta in the CLA-252 DIM experiment, incidence rates of 0.04 and 0.03 
cases/100 calvings for cows and heifers were recorded, respectively, while, in the CLA-PM-
105 DIM experiment the incidence rate was 0.29 cases/100 calvings. These rates are 
considered low compared to Borsberry and Dobson (1989) who reported 1.3 cases/100 
calvings in the UK. 
 
The current results showed that the concentrations of Hp ranged from 0.01 to 12.4 mg/mL (n 
= 49, CLA-252 DIM experiment), 0.01 to 9.0 mg/mL (n = 25, CLA-PM-105 DIM 
experiment) and 0.02 to 3.5 mg/mL (n = 20, concentrate-roughage ratio study). The animals 
in the latter mentioned study were generally healthy, and they had significantly lower 
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concentrations of Hp compared to the animals in the CLA studies. This confirms that Hp is a 
useful indicator of general health status in animals. For the non-lactating heifers (n = 12, fat 
heifers restriction study), the concentrations of Hp ranged from 0.05 to 0.11 mg/mL.  
 
Serum Hp concentrations were used to distinguish between healthy and diseased animals in 
the CLA-252 DIM experiment. A cut-off value of 0.16 mg/mL (59% sensitivity and 73% 
specificity) was obtained in the current study. Humblet et al. (2006) and Svensson et al. 
(2007) relate the poor sensitivity to the un-noticed subclinical health disturbances, which 
restricts the ability to identify animals with pathologic disorders. A cut-off value of 0.15 
mg/mL (72% sensitivity and 59% specificity) was reported in dairy cattle suffering from 
respiratory-tract disease (Svensson et al., 2007), and a cut-off value of 0.19 mg/mL (98% 
sensitivity and 100% specificity) was established to differentiate between healthy cows and 
cows with different inflammatory diseases (Khoshvaghti et al., 2009). In the current CLA 
studies, 5% of the CLA-252 DIM samples (total 874), and 11% of the CLA-PM-105 DIM 
samples (total 209) had higher concentrations of Hp than 0.16 mg/mL without any clinical 
finding. It is to be mentioned that in the present study the time of diagnosis may not truly 
reflect the exact time of the disease onset. It should be considered that in the absence of 
disease, the animal health could be influenced by environmental factors, handling, and other 
types of stress (Petersen et al., 2004). 
 
Chronic sub-clinical mastitis is a common problem in dairy herds with considerable economic 
losses, mainly due to reduced milk production and discarded milk. For successful mastitis 
control in a herd, rapid and accurate diagnosis of mastitic cows is crucial (Grönlund et al., 
2005). Sub-clinical mastitis is mostly diagnosed by cow-side tests like the California Mastitis 
Test or by analyses of SCC using automatic cell counters. Acute phase proteins are sensitive 
and accurate parameters for mastitis diagnosis. In the CLA-PM-105 DIM experiment, from 
total milk samples (n = 96), 44% of the samples were below the detection limit of 0.07 
µg/mL. The concentrations of Hp below the detection limit are considered as a good indicator 
of healthy udder quarters as reported by Grönlund et al. (2005). The concentrations of Hp in 
milk samples ranged from 0.07 to 0.74 µg/mL for healthy quarters and from 0.07 to 199 
µg/mL for diseased quarters, which is consistent with Hiss et al. (2007), who reported that 
concentrations of Hp in milk ranged from 0.35 to 16 µg/mL in sterile samples and from 0.35 
to 974 µg/mL in samples with pathogens. In addition, the SCC in milk is the most commonly 
used parameter in diagnosis of mastitis. Many studies reported the correlation between SCC 
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and APPs. In this study, a positive moderate correlation was found between the 
concentrations of milk Hp and SCC (r = 0.41, P = 0.001), while a very strong correlation (r = 
0.80) was reported by Hiss et al. (2007). In the study of Hiss et al. (2007), to be able to 
include sufficient animals with subclinical mastitis, the cows were preselected on the basis of 
their milk SCC (i.e. half of the cows selected had elevated milk SCC for at least two months), 
which was not the case in the present study since the animals were not preselected depending 
on their SCC. This might be a proper reason that the correlation in our study is lower than in 
the study of Hiss et al. (2007). 
 
4.5. Effect of fat mobilization on the concentrations of haptoglobin and leptin 
 
The fat heifers restriction study aimed mainly at revealing if the change in EB induced any 
change in the concentrations of Hp and leptin in Simmental heifers fed grass silage or a 
hay/silage-straw mixture of reduced energy content. However, the current results indicated 
that neither Hp nor leptin concentrations were affected by the change in energy content of the 
ration fed. The results of serum Hp are in line with Berry et al. (2004) who demonstrated that 
two dietary energy levels (3.56 or 4.48 MJ NE for gain (NEg)/kg of feed on DM basis) and 
two dietary starch levels (34 or 48% of dietary ME from starch) fed to bull and steer calves 
for 42 days had no effect on the concentrations of serum Hp.  
 
If leptin serves as an endocrine signal linking peripheral adipose stores to regulatory centers 
within the hypothalamus, changes in nutritional status should be accompanied by changes in 
the concentrations of serum leptin (Morrison et al., 2001). In sheep, restricted feeding (39% of 
the maintenance energy requirement (MER) for 3 days (Delavaud et al., 2000) and 38% of the 
MER for 14 weeks (Morrison et al., 2001) decreased the concentrations of plasma leptin. 
Also, in non-lactating, non pregnant Holstein cows initially fed at 130% of MER for 28 days, 
restricted to 21% of MER for 7 days, and re-fed to 237% of MER for 21 days, the 
concentrations of plasma leptin decreased by restricted feeding and increased after re-feeding 
(Delavaud et al., 2002). In the current study, the concentrations of leptin were not changed in 
animals fed hay/silage-straw mixture compared with animals fed grass silage. In addition, the 
re-feeding did not affect the concentrations of leptin in heifers fed hay/silage-straw mixture 
diet. Fasting has been reported to cause an inhibition of white AT leptin gene expression, 
which is tightly associated with decreasing leptin blood concentrations (Frühbeck, 2001). It is 
possible that the re-feeding causes an increase of leptin gene expression in white AT which is 
associated with an increase in the concentrations of serum leptin (Frühbeck, 2001). In view of 
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no effect of moderate feed restriction and re-feeding on the concentrations of Hp and leptin, it 
might be that the degree and the duration of feed restriction were not sufficient to induce any 
significant changes in the current study.  
 
During fat mobilization, there is a concurrent loss of body condition and AT mass. The 
amount and rate of tissue mobilization probably depend on several factors such as the fatness 
of the cows, diet composition and extent of the energy deficit. High yielding cows have been 
selected and bred to produce more milk, mostly through their ability to mobilize fat and 
muscle to support milk production in early lactation (Knop and Cernescu, 2009). This results 
in a loss of body condition and is associated with alterations in blood metabolite and hormone 
profiles (Kadokawa and Martin, 2006). In this situation, the cows rely on the mobilization of 
adipose reserves and they often lose 60% or more of their body fat in the first weeks after 
parturition (Knop and Cernescu, 2009). As discussed before in section 4.1, in the Holstein 
cows the concentrations of Hp and leptin were increased and decreased around calving, 
respectively, and both were influenced by the onset of NEB and mobilization of AT. While, in 
the Simmental heifers the change in EB did not alter the concentrations of Hp and leptin. 
Also, using the same animals that were used in the current study, Germeroth et al. (2011) 
reported that Simmental heifers had larger adipocyte sizes in SC AT than Holstein heifers 
(CLA-PM-105 DIM experiment), indicating that the Simmental heifers tend to increase body 
reserves, whereas Holstein heifers spend extra energy preferentially for milk production. The 
concentrations of leptin in Simmental heifers used in this study were higher (P < 0.001) than 
that in Holstein heifers used in the CLA-PM-105 DIM experiment, probably due to the 
differing physiological state (lactating vs. non-lactating heifers), body fatness (BCS = 5 in 
Simmental heifers vs. 3 in  Holstein heifers), and the nutritional conditions. Due to the higher 
concentrations of leptin and larger adipocyte sizes in the Simmental heifers compared with 
the Holstein heifers, it might be that the Simmental heifers display a lower attitude in 
mobilizing body reserve than the Holstein heifers. 
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5. Conclusions 
 
The current study clearly demonstrated that the physiological changes in the concentrations of 
serum Hp were related to parity and parturition. In addition, heifers had higher concentrations 
of Hp in the first week PP than cows. This observation suggests a more intense physiological 
response to first calving than to later ones. Moreover, this study explored that the increase in 
the concentrations of Hp in the first week PP could be partly related to the metabolic stress, as 
indicated by the relation between the concentrations of Hp and each of NEFA and BHB. 
Furthermore, the concentrations of Hp showed a stronger positive relation with NEFA in 
heifers than in cows; therefore it might be that heifers are more stressed by lipolysis than 
cows. 
Long-term supplementation with CLA (equal proportions of each c-9, t-11 and t-10, c-12 
isomers) after calving in cows and heifers left the concentrations of serum Hp and leptin 
unaffected. Taken together, in this study it is difficult to make any definitive conclusions on 
the effect of long-term CLA supplementation on Hp and leptin. It is likely that dose and 
isomeric composition of CLA separately affect the ability of CLA to influence the 
concentrations of Hp and leptin in dairy cows. However, the results of this study might open 
new aspects for further studies to focus on the dose and single action of the c-9, t-10 and the t-
10, c-12 CLA isomers on Hp and leptin. 
The IHC and Western immunoblotting confirmed the presence of Hp in AT. This result gives 
an indication that Hp could be classified as an adipokine in cattle. Therefore, more attention 
should be paid to investigate the function of this protein to provide information as to why Hp 
is present in bovine AT. In addition, the lack of an evident relation between the 
concentrations of serum Hp and body fatness in the present study makes Hp irrelevant as an 
adiposity marker for ruminants.  
Finally, it can be concluded that in response to NEB, Holstein cows mobilize stored 
triglycerides in the AT in an attempt to meet energy demands for maintenance and milk 
production. While, the Simmental heifers tend to increase body reserves and display a lower 
attitude in mobilizing body reserve than the Holstein cows. 
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6. Summary 
 
Timely changes of the circulating concentrations of haptoglobin and leptin in female 
cattle undergoing fat mobilization: assessment of the relevance of haptoglobin as an 
adipokine 
 
Dairy cattle production exposes animals to a variety of stressors which can reduce feed intake 
and disease resistance. During the transition period (3 weeks AP to 3 weeks PP), the energy 
requirements can not entirely be met through dietary intake resulting in a condition of NEB, 
and cows may experience adverse health events. Extensive metabolic and endocrine changes 
occur in dairy cows to accommodate parturition and lactogenesis. Dairy cows during this 
period are susceptible to various metabolic diseases, impaired immune function and fertility. 
Dairy cattle production has been looking for more efficient and effective ways to minimize 
these health problems for a long time. In the last decade, there was sharply increasing interest 
in CLA due to its potentially beneficial effects in terms of animal welfare, nutritional status 
and diseases. Haptoglobin, one of the major APPs in cattle, is synthesized in response to 
infection and inflammation. In healthy cattle, Hp blood concentrations are low or even 
undetectable, but increase up to 1000-fold in response to different inflammatory stimuli. 
Leptin is a protein secreted from AT and has been implicated in regulation of food intake, 
energy expenditure and whole-body EB. However, circulating concentrations of Hp and leptin 
under long-term CLA supplementation have not yet been investigated. In addition, less is 
known about other sites of Hp production in ruminants such as AT. Moreover, as early 
lactating cows favor mobilization of AT under conditions of NEB, the initial step in non-
lactating cows to overcome the energy deficit is the mobilization of an excessive quantity of 
AT. Therefore, this study was undertaken to characterize the concentrations of Hp and leptin 
throughout the entire lactation period or during early lactation, to investigate the potential 
effects of CLA supplementation on the concentrations of Hp and leptin in dairy cows, to 
examine the presence of Hp in bovine AT, and to examine the effect of moderate feed 
restriction and re-feeding on the concentrations of Hp and leptin in non-lactating, non-
pregnant heifers.  
Samples from four different studies were used in this work. The first experiment “CLA-252 
DIM” was conducted to characterize the concentrations of Hp and leptin throughout lactation 
and to evaluate the effects of two different doses of rumen-protected CLA (50 and 100 g/d) 
supplemented from d 1 to 182 PP. This experiment comprised heifers (n = 16) and cows (n = 
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33) observed from d 21 AP until d 252 PP. In addition, a further experiment “CLA-PM-105 
DIM” was done in heifers (n = 25) studied from d 21 AP until d 105 PP and received 100 g/d 
CLA supplementation. The animals were sequentially slaughtered (d 1, 42 or 105 PP) for 
collection of PM tissue samples (3 VC and 3 SC depots). The CLA supplementation started 
on d 1 PP and continued until slaughter. In both experiments, the CLA supplementation 
included 12% (of total FA) of the t-10, c-12 and c-9, t-11 CLA isomers in equal parts. The 
third experiment “Concentrate-roughage ratio” was conducted using cows (n = 20) 
investigated from d 21 AP until d 21 PP, and received diets after calving with either a 
concentrate-to-roughage ratio on a dry matter basis of 30:70% (low-concentrate group) or 
60:40% (high-concentrate group). To examine the effect of moderate feed restriction and re-
feeding, a fourth experiment “Fat heifers restriction” with 12 non-lactating, non-pregnant 
heifers was performed. The heifers were fed either grass silage (100%) or grass silage diluted 
with straw (37:63 on DM basis). Serum and milk Hp, and serum leptin concentrations in the 
collected samples were detected using a competitive ELISA. Haptoglobin in AT was detected 
using IHC and Western immunoblotting. 
The physiological changes of Hp observed during the CLA-252 DIM experiment were related 
to parity (heifers vs. cows; P < 0.05) and parturition (before vs. after parturition; P < 0.001). 
The concentrations of Hp were 1.7-fold higher in heifers than in cows during the first week 
PP. The concentrations of Hp peaked around calving and decreased afterwards for both parity 
groups. In the CLA-PM-105 DIM experiment, the concentrations of Hp in heifers were 
affected by parturition (P < 0.001) with elevated concentrations during the first week PP and 
decreased afterwards. In both experiments, the time course of the concentrations of Hp after 
the first week PP did not show marked changes. Long-term feeding of dairy cows with CLA 
had no significant effect on the concentrations of serum Hp. No relationship was established 
between serum Hp and each of BCS, BW and body fat content in both CLA experiments. A 
positive relation was observed between the concentrations of Hp and NEFA in both CLA 
experiments, and this relation was stronger in heifers than in cows. In both CLA studies, the 
clinical examination of the animals revealed disorders of their general health conditions such 
as mastitis, metritis and retained placenta. The incidence rates of these diseases were 
determined. A cut-off point of 0.16 mg/mL with 59% sensitivity and 73% specificity was 
determined for the concentrations of serum Hp in the CLA-252 DIM experiment to 
discriminate between healthy and diseased animals. The IHC confirmed that Hp is present in 
all tested bovine AT. The VC fat had higher (P < 0.05) portions of Hp positive cells than SC 
fat. The Western immunoblotting indicated the presence of Hp in AT, and demonstrated 
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differences in the obtained molecular weights of SC tailhead fat (26 and 55 kDa) compared to 
liver or serum (34, 26 and 20 kDa).  
The physiological alterations in the concentrations of serum leptin in the CLA-252 DIM 
experiment were limited to parturition (before vs. after parturition; P < 0.001), whereas no 
parity (heifers vs. cows) differences could be confirmed. In both CLA studies, the 
concentrations of leptin were high in the AP period, and then decreased in the PP period 
below the pregnancy concentrations. Long-term feeding of dairy cows with CLA left the 
concentrations of serum leptin unaffected. The concentrations of leptin had a stronger relation 
with fat mass, body fat content, and adipocyte size than BCS.  
The fat heifers restriction study indicated that neither Hp nor leptin concentrations were 
affected by the change in energy content of the ration fed. The re-feeding (hay/silage-straw 
mixture to grass silage) had no significant effect on the concentrations of leptin.  
In conclusion, the physiological changes observed in the CLA-252 DIM experiment in the 
concentrations of serum Hp were related to parity and parturition. During the first week PP, 
the concentrations of Hp were higher in heifers than in cows, suggesting a more intense 
physiological response to first calving than to later ones. This study explored that the 
metabolic stress might modulate part of the increase in the concentrations of Hp in the first 
week PP as indicated by the relation between the concentrations of Hp and NEFA. Long-term 
feeding of dairy cows with CLA (equal proportions of each the c-9, t-11 and the t-10, c-12 
isomers) had no significant effect on the concentrations of serum Hp and leptin. However, the 
c-9, t-10 and the t-10, c-12 CLA isomer might divergently affect Hp and leptin. The presence 
of Hp in bovine AT indicates that Hp can be classified as an adipokine in cattle. The lack of 
an evident relation between the concentrations of Hp and body fatness in this study makes Hp 
irrelevant as an adiposity marker for ruminants.  
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7. Zusammenfassung  
 
Zeitlicher Verlauf der zirkulierenden Konzentrationen von Haptoglobin und Leptin in 
weiblichen Rindern, die eine Fettmobilisierung durchleben: Einschätzung der Relevanz 
von Haptoglobin als Adipokin   
 
Milchproduktion setzt die Tiere einer Vielzahl von Stressoren aus, die zu reduzierter 
Futteraufnahme und verminderter Krankheitsresistenz führen können. In der 
Transitionsperiode (3 Wochen vor der Geburt bis 3 Wochen nach der Geburt) können die 
Energieanforderungen durch die Futteraufnahme nicht mehr gedeckt werden, was zu einer 
NEB führt; dadurch sind Kühe nachteiligen Gesundheitsveränderungen ausgesetzt. Folglich 
resultieren daraus metabolische und endokrine Veränderungen um die Geburt und 
Milchproduktion zu gewährleisten. Milchkühe in diesem Zeitraum sind anfällig für eine Reihe 
metabolischer Erkrankungen, verminderter Immunfunktion und reduzierte Fruchtbarkeit. In 
der Produktion im Milchviehsektor wird schon seit langem nach effektiven Wegen gesucht, 
um die Gesundheitsprobleme der Kühe in dieser Zeit zu minimieren. Im letzten Jahrzehnt hat 
das Interesse an CLA zugenommen auf Grund deren potentiell positiver Wirkung auf das 
Wohlbefinden des Tieres, den Fütterungszustand und in Bezug auf Krankheiten. Haptoglobin 
ist eines der wichtigsten Akute Phase Proteine bei Rindern das als Antwort auf Infektion und 
Entzündung produziert wird. Bei gesunden Rindern sind die Blut Hp-Konzentrationen sehr 
niedrig bis nicht detektierbar, aber auf inflammatorische Stimulation können sie um das 1000-
fache ansteigen. Leptin ist ein Protein, das vom Fettgewebe produziert wird, es ist in die 
Regulation der Futteraufnahme involviert und gibt Auskunft über den Energiezustand und die 
Energiebilanz des Körpers. Zirkulierende Konzentrationen von Hp und Leptin unter längerer 
CLA-Supplementierung wurden noch nicht untersucht. Außerdem ist wenig bekannt über 
andere Gewebe die Hp in Wiederkäuern synthetisieren, wie das Fettgewebe. Außerdem 
begünstigen die ersten Tage der Laktation einer Kuh, die Fettmobilisierung aus dem 
Fettgewebe unter NEB, der erste Schritt nicht laktierender Kühe das Energiedefizit zu 
überwinden ist die exzessive Mobilisierung von Fett.  
Diese Studie wurde durchgeführt, um die Konzentrationen von Hp und Leptin über die 
komplette Laktation und über die ersten Tage der Laktation zu charakterisieren, den 
potentiellen Effekt der CLA-Supplementation auf Hp- und Leptinkonzentrationen in 
Milchkühen zu erforschen, das Vorkommen von Hp in bovinem Fettgewebe und den Effekt 
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von moderater Futterrestriktion und Wiederaufnahme der Fütterung in nicht laktierenden, 
nicht tragenden Färsen zu zeigen.  
Proben aus vier verschiedenen Versuchen wurde für diese Studie verwendet. Der erste 
Versuch “CLA-252 DIM” wurde durchgeführt, um die Konzentrationen von Hp und Leptin 
über eine Laktation zu charakterisieren und um die Effekte der Fütterung von zwei 
verschiedenen Dosen pansengeschützer CLA (50 und 100 g/d) zu evaluieren, die von d 1 bis d 
182 nach der Geburt gefüttert wurden. Dieser Versuch umfasste Färsen (n = 16) und Kühe (n 
= 33), die von d 21 bis d 252 nach der Geburt untersucht wurden. Zusätzlich wurde ein 
weiterer Versuch “CLA-PM-105 DIM” mit Färsen (n = 25) durchgeführt, die 100 g CLA/d 
gefüttert bekamen. Die Tiere wurden nacheinander für die Gewinnung von post mortalen 
Gewebeproben (3 viszerale und 3 subkutane Fett-depots) geschlachtet (d 1, 42 oder 105 PP). 
Die CLA Supplementierung begann an d 1 nach der Geburt bis hin zur Schlachtung.  In 
beiden Versuchen enthielten die zugefütterten CLA zu je 12% (der Gesamtfettsäuren) die t-
10, c-12 und die c-9, t-11 Isomere. Der dritte Versuch “Kraftfutter Rauhfutter Verhältnis” 
(KF:R) (d 21 AP - d 21 PP) wurde mit Kühen durchgeführt, deren Rationen bezogen auf 
Trockenmasse geringe (KF:R = 30:70%) oder hohe (KF:R = 60:40%) KF-Anteile nach der 
Kalbung enthielten. Um den Effekt von moderater Futterrestriktion und Wiederfütterung zu 
untersuchen, wurde ein vierter Versuch “Fette Färsen” mit 12 nicht laktierenden, nicht 
tragenden Färsen durchgeführt. Die Färsen bekamen entweder Grassilage (100%) oder 
Grassilage verdünnt mit Stroh (37:63 bezogen auf Trockenmasse). Serum und Milch Hp- und 
Serum-leptinkonzentrationen wurden mittels kompetitivem ELISA bestimmt. Haptoglobin in 
Fettgewebe wurde mit Immunhistochemie und Western Blot detektiert.  
Die physiologischen Veränderungen von Hp im CLA-252 DIM Versuch standen im 
Zusammenhang zu Parität (Färsen vs. Kühe; P < 0,05) und Geburt (vor vs. nach der Geburt; P 
< 0,001). Die Konzentration von Hp bei Färsen war 1,7-fach höher als bei Kühen in der ersten 
Woche nach der Geburt. In beiden Paritätsgruppen und CLA Versuchen konnte gezeigt 
werden, dass Hp eine maximale Konzentration zum Zeitpunkt der Geburt hatte und 
anschließend wieder absank. Im CLA-PM-105 DIM Versuch war die Hp-Konzentration in 
Färsen durch die Geburt beeinflusst (P < 0,001), erhöhte Konzentrationen wurden in der 
ersten Woche nach der Geburt gemessen, die danach wieder absanken. In beiden Versuchen 
zeigte der zeitliche Verlauf der Hp-Konzentration nach der ersten Woche PP keine auffälligen 
Veränderungen. Die CLA-Fütterung von Milchkühen über einen längeren Zeitraum zeigte 
keine signifikanten Effekte auf die Hp-Konzentration. In beiden CLA-Gruppen konnte kein 
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Zusammenhang zwischen Serum-Hp und BCS, Körpergewicht und Körperfettanteil ermittelt 
werden. Ein positiver Zusammenhang konnte zwischen der Hp- und NEFA-Konzentration in 
beiden CLA-Versuchen ermittelt werden, die Beziehung bei den Färsen war stärker als die bei 
den Kühen. In beiden CLA-Studien wurden durch klinische Untersuchungen verschiedener 
Erkrankungen, wie Mastitis, Metritis und retinierter Plancenta, festgestellt. Die 
Häufigkeitsraten dieser Erkrankungen wurden notiert. Ein Cut-off-Wert von 0,16 mg Hp/mL 
mit 59% Sensitivität und 73% Spezifität im CLA-252 DIM Versuch wurde ermittelt, um 
zwischen gesunden und kranken Tieren zu differenzieren.  
Die IHC bestätigte, dass Hp in allen getesteten Fettgeweben der Kuh vorkommt. Im 
viszeralen Fettgewebe wurden mehr Hp-postitive Zellen (P < 0,05) gefunden als im 
subkutanen. Durch Western Blot konnte das Vorkommen von Hp im Fettgewebe und 
unterschiedliche Molekulargewichte des Haptoglobins im subkutanen Schwanzfett (26 und 55 
kDa) verglichen mit Leber und Serum (34, 26 und 20 kDa) gezeigt werden. Die 
physiologischen Veränderungen in der Serum-Leptinkonzentration im CLA-252 DIM 
Versuch waren beschränkt auf die Geburt (vor vs. nach der Geburt; P < 0,001) wohingegen 
keine Paritätsunterschiede (Färsen vs. Kühe) festgestellt werden konnten. In beiden CLA-
Versuchen war die Leptinkonzentration in der Zeit AP hoch und sanken in der Zeit PP bis 
unter die Konzentration während der Trächtigkeit ab. Langzeitsupplementation von Kühen 
mit CLA hatte keinen Einfluss auf die Serum-Leptinkonzentration. Die Leptinkonzentration 
stand in stärkerer Beziehung zur Köperfettmasse, Köperfettanteil und der Adipozytengröße 
als zum BCS. Die “Fette Färsen” Studie zeigte, dass weder Hp- noch Leptinkonzentrationen 
durch Änderungen im Energiegehalt der Ration beeinflusst wurden. Wiederaufnahme der 
Fütterung (Grassilage vs. Heu/Grassilage-Stroh-Mischung) hatte keinen Effekt auf die 
Leptinkonzentration.  
Folglich waren die physiologischen Veränderungen in der Serum-Hp-Konzentration, die im 
CLA-252 DIM Versuch beobachtet wurden, auf die Parität und Geburt zurückzuführen. 
Während der ersten Woche PP waren die Hp-Konzentrationen in Färsen höher als in Kühen, 
was auf eine intensivere physiologische Antwort auf die erste Geburt als auf die Späteren 
hinweist. In dieser Studie wurde gezeigt, dass metabolischer Stress zumindest teilweise für 
einen Anstieg der Hp-Konzentrationen in der ersten Woche nach der Geburt verantwortlich 
ist, was über eine Beziehung zwischen Hp- und NEFA-Konzentration erklärt werden kann. 
Langzeitfütterung von Kühen mit einer CLA-Mischung, die gleiche Teile der c-9, t-11 und t-
10, c-12 Isomere enthält, hatte keinen signifikanten Einfluss auf die Serum-Konzentrationen 
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von Hp und Leptin. Dennoch könnten die c-9, t-11 und t-10, c-12 Isomere Hp und Leptin 
unterschiedlich beeinflussen. Das Vorkommen von Hp in bovinem Fettgewebe indiziert, dass 
Hp bei Rindern als Adipokin klassifiziert werden kann. Der fehlende Zusammenhang 
zwischen Hp und Körperfettgehalt macht Hp irrelevant als Marker für Fettleibigkeit in 
Wiederkäuern.  
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9. Appendixes 
 
Appendix A - Animal diets 
 
Tab. A1. Ingredients and chemical composition of the ante partum diet in the CLA-252 
DIM experiment. 
 
              PMR1 Concentrate 
Corn silage Grass silage          
Components (%) 
Wheat grain 
Barley grain 
Soybean meal 
Sugar beet pulp (dried) 
Zeolithe2  
Vitamin/mineral premix3  
 
   
25 
25 
20 
11 
12.5 
6.5 
Chemical composition 
DM (g/kg) 
 
295 
 
457 
 
877 
 
Nutrients (g/kg of DM) 
Crude ash 
Crude protein  
Ether extract 
ADF 
NDF 
 
40 
66 
31 
238 
445 
 
106 
113 
32 
332 
555 
 
83 
179 
31 
66 
189 
 
Energy4 (MJ/Kg DM) 
ME 
NEL 
 
10.6 
6.4 
 
9.2 
5.4 
 
10.6 
6.7 
1Partial mixed ration on DM basis (60% corn silage, 40% grass silage). 
2According to Grabherr et al. (2009) cows received 250 g Zeolithe/d for prevention of hypocalcaemia. 
3Per kg mineral feed: 60 g Ca, 105 g Na, 80 g P, 50 g Mg, 7 g Zn, 5.4 g Mn, 1.25 g Cu, 100 mg I, 40 mg Se, 30 
mg Co, 800 000 IU vitamin A, 100 000 IU vitamin D3, 1500 mg vitamin E. 
4Calculation based on nutrient digestibilities measured with wethers (GfE, 1991) and tabulated values 
(Universität Hohenheim-Dokumentationsstelle, 1997). 
Abbreviations: ADF = Acid detergent fiber, DM = Dry matter, ME = Metabolizable energy, NDF = Neutral 
detergent fiber, NEL = Net energy lactation. 
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Tab. A2. Ingredients and chemical composition of post partum fed concentrate and 
partial mixed ration in the CLA-252 DIM experiment (modified after Pappritz 
et al., 2011). 
 
 Concentrate PMR1 
CTR CLA  
Ingredients (%) 
Wheat grain 
Sugar beet pulp (dried) 
Rapeseed meal 
Soybean meal 
Soybean oil 
Calcium carbonate 
Vitamin/mineral premix2 
CLA supplement 
Control fatty acid  
 
 
38.5 
29 
20 
6.5 
1 
0.50 
2 
 
2.5 
 
38.5 
29 
20 
6.5 
1 
0.50 
2 
2.5 
 
 
Analyzed chemical profile 
DM (g/kg) 
 
 
889 
 
887 
 
426 
Nutrients (g/kg DM) 
Crude ash 
Crude protein  
Ether extract 
Crude fiber 
ADF 
NDF 
 
 
71 
187 
59 
88 
123 
258 
 
74 
187 
53 
89 
124 
256 
 
69 
118 
32 
193 
225 
425 
Energy3 (MJ/Kg DM) 
ME 
NEL 
CLA (g/kg of DM) 
t-10, c-12 CLA                      
 
13.9 
8.8 
 
0.02 
 
13.8 
8.8 
 
2.25 
 
11.1 
6.8 
 
 0.01 
1Partial mixed ration (63% silage, 37% PMR-concentrate on DM basis). 
2Per kg mineral feed: 140 g Ca, 120 g Na, 70 g P, 40 g Mg, 6 g Zn, 5.4 g Mn, 1 g Cu, 100 mg I, 40 mg Se, 5 mg 
Co, 1 000 000 IU Vitamin A, 100 000 IU Vitamin D3, 1500 mg Vitamin E. 
3Calculation based on nutrient digestibilities measured with wethers (GfE, 1991). 
Abbreviations: ADF = Acid detergent fiber, c = cis, CLA = Conjugated linoleic acids, DM = Dry matter, ME = 
Metabolizable energy, NDF = Neutral detergent fiber, NEL = Net energy lactation, t = trans. 
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Tab. A3. Fatty acids profile of fat supplements1 in the CLA-252 DIM and the CLA-PM-
105 DIM experiments (modified after Pappritz et al., 2011; von Soosten et al., 
2011). 
 
Fatty acids (% of total fatty acids) CTR CLA 
Palmitic acid (C16:0)  
Stearic acid (C18:0)  
Oleic acid (C18:1 c-9)  
 
10.89 
87.30 
<0.01       
10.89 
50.31 
10.66 
Conjugated linoleic acids (CLA) 
C18:2 c-9, t-11 
C18:2 t-10, c-12 
 
 
0.06 
0.02 
 
11.99 
11.88 
Other CLA 
 
0.15 0.95 
Other fatty acids 1.58 3.32 
1Supplementation CLA was included in the concentrate portion (fed by the computerized concentrate 
feeding station) as a rumen-protected CLA preparation. For the control group, CLA was distributed by 
stearic acid (C18:0).  
 
Tab. A4. Ingredients and chemical composition of the ante partum diet in the CLA-PM-
105 DIM experiment (von Soosten et al., 2011). 
 
 Concentrate PMR1 
Ingredients (%) 
Wheat grain  
Barley grain 
Soybean meal  
Sugar beet pulp (dried) 
Zeolithe2 
Vitamin/mineral premix3 
 
 
25 
25 
20 
11 
12.5 
6.5 
 
 
Chemical composition 
DM (g/kg) 
 
 
894 
 
375 
Nutrients (g/kg DM) 
Crude ash 
Crude protein 
Ether extract 
Crude fiber 
ADF 
NDF 
 
 
155 
173 
22 
51 
68 
157 
 
56 
89 
29 
232 
256 
469 
Energy4 (MJ/kg DM) 
ME 
NEL 
 
10.6 
6.7 
 
11.0 
6.7 
1Partial mixed ration on DM basis (60% corn silage, 40% grass silage). 
2According to Grabherr et al. (2009) cows received 250 g Zeolithe/d for prevention of hypocalcaemia. 
3Per kg mineral feed: 60 g Ca, 105 g Na, 80 g P, 50 g Mg, 7 g Zn, 5.4 g Mn, 1.25 g Cu, 100 mg I, 40 mg Se, 30 
mg Co, 800 000 IU vitamin A, 100 000 IU vitamin D3, 1500 mg vitamin E. 
4Calculation based on nutrient digestibilities measured with wethers (GfE, 1991) and tabulated values 
(Universität Hohenheim-Dokumentationsstelle, 1997).  
Abbreviations: ADF = Acid detergent fiber, DM = Dry matter, ME = Metabolizable energy, NDF = Neutral 
detergent fiber, NEL = Net energy lactation. 
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Tab. A5. Ingredients and chemical composition of post partum concentrate and partial 
mixed ration in the CLA-PM-105 DIM experiment (von Soosten et al., 2011). 
 
 
 
Concentrate PMR1 
CTR CLA PMR1  
Ingredients (%) 
Wheat grain 
Sugar beet pulp (dried) 
Rapeseed meal 
Soybean meal 
Vitamin/mineral premix2 
Control fat supplement 
CLA supplement 
Calcium carbonate 
 
 
39.5 
29 
20 
6.5 
2 
2.5 
- 
0.5 
 
39.5 
29 
20 
6.5 
2 
- 
2.5 
0.5 
 
41 
30 
20 
6.5 
2 
- 
- 
          0.5 
 
 
Analyzed chemical profile 
DM (g/kg) 
 
 
873 
 
871 
 
870 
 
445 
Nutrients (g/kg DM) 
Crude ash 
Crude protein 
Ether extract 
ADF 
NDF 
 
 
65.2 
182 
50 
134 
259 
 
69 
180 
44 
133 
260 
 
64 
182 
20 
134 
265 
 
62 
124 
28 
208 
405 
Energy3 (MJ/kg DM) 
ME 
NEL 
CLA (g/kg of DM) 
C18:2 t-10, c-12 
C18:2 c-9, t-11 
 
13.9 
8.9 
 
0.0 
0.0 
 
13.7 
8.7 
 
1.7 
1.6 
 
13.5 
8.7 
 
0.0 
0.0 
 
11.9 
7.5 
 
0.0 
0.0 
1Partial mixed ration (25% grass silage, 38% corn silage, 37% PMR-concentrate). 
2Per kg mineral feed: 140 g Ca, 120 g Na, 70 g P, 40 g Mg, 6 g Zn, 5.4 g Mn, 1 g Cu, 100 mg I, 40 mg Se, 5 mg 
Co, 1 000 000 IU vitamin A, 100 000 IU vitamin D3, 1500 mg vitamin E. 
3Calculation based on nutrient digestibilites measured with wethers (GfE, 1991). 
Abbreviations: ADF = Acid detergent fiber, c = cis, CLA = Conjugated linoleic acids, DM = Dry matter, ME = 
Metabolizable energy, NEL = Net energy lactation, NDF = Neutral detergent fiber, t = trans. 
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Tab. A6. Nutrient, fibre and energy contents of the feed ingredients as well as intended 
percentages of silage and concentrate in the diets fed to cows post partum in 
the concentrate-roughage ratio study (Locher et al., 2011). 
 
              Feeding component 
Item Corn silage Grass silage LC  HC 
DM (g/kg) 368 289 885 883 
Ash (g/kg DM) 37 138 53 66 
CP (g/kg DM) 80 159 218 210 
EE (g/kg DM) 32 40 29 27 
ADF (g/kg DM) 223 311 52 53 
NDF (g/kg DM) 424 514 146 163 
ME (MJ/kg DM) 10.71 10.81 13.12 12.92 
NEL (MJ/kg DM) 6.41 6.51 8.32 8.22 
% in LC diet 42 28 30 - 
% in HC diet 24 16 - 60 
1Calculation based on nutrient digestibilities measured with wethers (GfE, 1991). 
2Calculation based on analyzed nutrient contents and tabulated values of apparent digestibilities (Universität 
Hohenheim-Dokumentationsstelle, 1997). 
Abbreviations: ADF = Acid detergent fiber, CP = Crude protein, DM = Dry matter, EE = Ether extract, HC = 
High concentrate, LC = Low concentrate, ME = Metabolizable energy, NDF = Neutral detergent 
fiber, NEL = Net energy lactation. 
 
Tab. A7. Chemical composition and energy contents of grass silage and hay/silage-straw 
mixture in the fat heifers feed restriction study (unpublished data). 
 
                                      Feeding component 
Item Grass silage Hay/silage-straw 
mixture 
DM (%) 37 63 
CP (%) 10.6 8.5 
ADF (%) 34.6 37 
NDF (%) 54.8 63.2 
ME (MJ/kg DM) 9.5 8.1 
                  Abbreviations: ADF = Acid detergent fiber, CP = Crude protein, DM = Dry matter, ME 
Metabolizable energy, NDF = Neutral detergent fiber. 
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Appendix B - Correlations 
 
Tab. B1. Coefficients of correlation between the concentrations of serum haptoglobin 
and body condition score, body weight, concentrations of nonesterified fatty 
acids and β-hydroxybutyrate during different periods in the conjugated 
linoleic acid studies. 
 
 
Experiment 
 
                Cows 
 
               Heifers 
Period BCS BW NEFA BHB 
 
BCS BW NEFA BHB 
CLA-252 
DIM  
21 AP - 252 PP - - 0.14*** 0.12***  - - 0.38*** - 
21 AP - 7 AP - - - -  - - - - 
1 PP - 252 PP - - 0.10* 0.11*  - - 0.43*** - 
1 PP - 182 PP - - 0.12* 0.17**  - - 0.56*** - 
189 PP - 252 PP - - 0.26*** -  - - - - 
 
CLA-PM-
105 DIM  
21AP - 105 PP 
    
 - - 0.54*** 0.20** 
21 AP - 7 AP 
    
 - - 0.46*** - 
1 PP - 105 PP 
    
 - - 0.49*** 0.23** 
* P ≤ 0.05, ** P ≤ 0.01, *** P ≤ 0.001. 
Abbreviations: AP = Ante partum, BCS = Body condition score, BHB = β-hydroxybutyrate, BW = Body weight, 
NEFA = Nonesterified fatty acids, PP = Post partum. 
 
 
Tab. B2. Coefficients of correlation between the concentrations of serum leptin and 
body condition score, body weight, concentrations of nonesterified fatty acids 
and β-hydroxybutyrate during different periods in the CLA-252 DIM and 
CLA-PM-105 DIM experiments. 
 
 
Experiment 
 
               All animals 
 
                    Heifers 
Period BCS BW NEFA BHB 
 
BCS BW NEFA BHB 
CLA-252 
DIM  
21 AP - 252 PP 0.19*** - -0.15*** -      
21 AP - 7 AP - - - -      
1 PP - 252 PP - - -0.11** -      
1 PP - 182 PP - -  -0.10* -      
189 PP - 252 PP 0.18** - - -      
 
CLA-PM-
105 DIM  
21AP - 105 PP - - - -  - - - - 
21 AP - 7 AP - - - -   0.27* - - - 
1 PP - 105 PP - - - -   0.34*** 0.46*** - 0.34*** 
* P ≤ 0.05, ** P ≤ 0.01, *** P ≤ 0.001. 
Abbreviations: AP = Ante partum, BCS = Body condition score, BHB = β-hydroxybutyrate, BW = Body weight,  
NEFA = Nonesterified fatty acids, PP = Post partum. 
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Tab. B3. Coefficients of correlation between the concentrations of serum leptin and fat 
mass, adipocyte size and body fat content of different fat depots for the heifers 
in the CLA-PM-105 DIM experiment. 
 
      Fat mass (kg)     Adipocyte size (µm2)  
  Body fat content (%) 
1 PP 42 PP 105 PP 1 PP 42 PP 105 PP 1 PP 42 PP 105 PP 
SC depots 
Tailhead 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
Withers  - - - - -   0.78** - - - 
Sternum - - - - - 0.71* - - - 
Mean SC - 0.83** - - - - - 0.80** - 
 
VC depots           
Omental 
Mesenterial 
Retroperitoneal 
- 
- 
- 
  0.90*** 
0.71* 
0.81** 
- 
- 
- 
- 
  0.98** 
- 
- 
- 
- 
- 
- 
 0.75* 
- 
- 
- 
0.86*** 
0.72* 
0.83** 
- 
- 
- 
 
* P ≤ 0.05, ** P ≤ 0.01, *** P ≤ 0.001. 
Abbreviations: PP = Post partum, SC = Subcutaneous, VC = Visceral 
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Appendix C - Chemicals, buffers and solutions 
 
Enzyme-linked immunosorbent assay (ELISA) 
 
Protease inhibitor CompleteTM    (Roche) 
1 tablet in 2 mL H2O 
 
Coating buffer 
0.05 M NaHCO3      (Roth) 
200 µL/L Protease inhibitor      
20 mL/L Proclin 150®      (Sigma) 
pH 9.6 
 
Casein solution 
0.05 M NaOH                                                                        (Applichem) 
1.5 mM EDTA (Disodium salt dihydrate)                             (Roth) 
2.5% Casein                                                                           (Sigma) 
200 µL/L Protease inhibitor 
20 mL/L Proclin 150®  
pH 7.2 
 
Test buffer  
0.12 M NaCl                                                                          (Roth) 
0.02 M Na2HPO4                                                                   (AppliChem) 
0.01 M EDTA                                                                        (Roth) 
0.005% Chlorhexidine                                                           (Sigma) 
0.1% Gelatine (Gelatine Hydrolysate)                                  (Sigma) 
0.05% Tween®20                                                                   (AppliChem) 
0.002% Phenol red                                                                 (Sigma) 
200 µL/L Protease inhibitor 
20 mL/L Proclin 150® 
pH 7.3 
 
Substrate buffer 
0.05 M Citric acid                                                                  (AppliChem) 
0.055 M Na2HPO4                                                                     
0.05% Urea peroxide                                                             (Sigma) 
20 mL/L Proclin 150® 
pH 4.05 
 
TMB-solution 
12.5 mg TMB (3, 3, 5, 5-Tetramethylbenzidine)                   (AppliChem) 
1 mL DMSO (Dimethyl sulfoxide)                                        (AppliChem) 
                                                                  
Substrate solution 
18 mL Substrate buffer 
360 µL TMB-solution 
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Stop solution 
1 M Oxalic acid                                                                   (Roth) 
 
Washing buffer (10-fold) 
1.36 M NaCl 
81 mM Na2HPO4                                                                         
27 mM KCl                                                                          (Roth) 
15 mM KH2PO4                                                                   (Roth) 
20 mL/L Proclin 150® 
55 g/L Tween®20 
pH 7.3 
To prepare a ready-made solution: 10 mL of washing buffer/1 L 
 
Immunohistochemistry (IHC) 
 
PBS (Phosphate buffered saline) 
0.136 M NaCl         
8.1 mM Na2HPO4 
2.7 mM KCl 
1.5 mM KH2PO4 
pH 7.2 
 
Washing buffer 
0.136 M NaCl 
8.1 mM Na2HPO4  
2.7 mM KCl 
1.5 mM KH2PO4 
0.5 ml (0.05%) Tween®20 
pH 7.2 
Filled up with H2O (1 L) 
 
Citrate buffer 
0.01 mM Citric acid, Anhydrous 
pH 6 
Filled up with H2O (1 L) 
 
Hydrogen peroxide (H2O2) 
100 µL H2O2                                                                        (Roth) 
1 mL PBS 
 
Western immunoblotting 
 
Resolving buffer 
1.5 M Tris (hydroxymethyl aminomethane)/HCl                (Roth)    
0.4% SDS (Sodium dodecyl sulfate)                                   (Sigma) 
pH 8.8 
 
Resolving gel (12%) 
4 mL Acrylamide (30%) (Rotiphorese® Gel A)                  (Roth)  
1.6 mL Bisacrylamide (2%) (Rotiphorese® Gel B)             (Roth)  
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2.50 mL Resolving buffer 
1.9 mL H2O 
The above mixture mixed with: 
45 µL 10% Ammonium persulfate (APS)                            (Sigma)  
5 µL Tetramethylenediamine (TEMED)                              (Roth)  
 
Stacking buffer 
0.5 M Tris/HCl    
0.4% SDS 
pH 6.8 
 
Stacking gel (5.6%) 
0.40 mL Acrylamide (30%)     
0.265 mL Bisacrylamide (2%) 
0.625 mL Stacking buffer 
1.71 mL H2O 
The above mixture mixed with: 
20 µL 10% APS 
5 µL TEMED 
 
Running buffer (10-fold) 
25 mM Tris                                                                          (Roth) 
0.2 M Glycine 
0.1% SDS 
 
Bromphenol blue solution 
0.2% Bromophenol blue                (Sigma) 
0.1 M Tris/HCl  
pH 7.5 
 
Sample buffer (2-fold) 
3 mL Bromophenol blue solution            
40 mL Glycerine                                                                  (Merck) 
4 mL 2-Mercaptoethanol                                                     (Sigma) 
10 mL 20% SDS 
4 mL 1M Tris/HCl  
pH 6.8 
Filled up with H2O (1 L),  
for 5-fold filled up with 40 mL H2O 
 
Tris/HCl 
0.1 M Tris/HCl 
pH 7.5 
 
Blotting buffer I 
0.3 M Tris/HCl 
10% methanol                 (AppliChem) 
pH 10.4 
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Blotting buffer II 
25 mM Tris/HCl 
10% methanol 
pH 10.4 
 
Blotting buffer III 
25 mM Tris/HCl 
10% methanol 
60 mM 6-Aminohexanoic acid 
pH 9.4 
 
TBS buffer (10-fold) 
0.05 M Tris/HCl 
0.9% NaCl 
pH 7.5 
 
TBST (Tris-Buffered Saline-Tween)  
0.5 mL (0.05%) Tween®20 
1 L TBS 
pH 7.3-7.4 
 
TBST with Roti®block 
9 mL TBST 
1 mL Roti® block 
 
Fat and liver samples homogenization 
 
Homogenization buffer 
50 mM Tris HCl 
300 mM KCl 
2.5 mM MgCl2 
pH 7 
 
Protease inhibitor CompleteTM 
1 tablet in 2 mL H2O 
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